<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mtx="http://mineralstech.com/20260405"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mtx-20260405.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
        </entity>
        <period>
            <instant>2026-04-22</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
        </entity>
        <period>
            <instant>2025-03-30</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-30</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-30</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-30</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-30</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-30</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-30</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:HouseholdAndPersonalCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:ConsumerAndSpecialtiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:HouseholdAndPersonalCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:ConsumerAndSpecialtiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:SpecialtyAdditivesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:ConsumerAndSpecialtiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:SpecialtyAdditivesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:ConsumerAndSpecialtiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:ConsumerAndSpecialtiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:ConsumerAndSpecialtiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:HighTemperatureTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:EngineeredSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:HighTemperatureTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:EngineeredSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:EnvironmentalAndInfrastructureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:EngineeredSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:EnvironmentalAndInfrastructureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:EngineeredSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:EngineeredSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:EngineeredSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-30</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:ConsumerAndSpecialtiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:ConsumerAndSpecialtiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:EngineeredSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:EngineeredSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mtx:PatentsAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mtx:PatentsAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-02</instant>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:RefinancingRevolvingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-26</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:TermLoanDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-26</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-11</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:SeniorSecuredRevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-11</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:RefinancingRevolvingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:TermLoanDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:RefinancingFacilityAgreementAndIncrementalFacilityAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:SeniorNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:RefinancingFacilityAgreementAndIncrementalFacilityAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:RefinancingRevolvingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mtx:TermSofrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:RefinancingRevolvingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:RefinancingRevolvingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mtx:EuroInterbankOfferedRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:RefinancingRevolvingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mtx:SterlingOvernightIndexAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:RefinancingRevolvingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:RefinancingRevolvingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:TermLoanDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mtx:TermSofrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:TermLoanDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:SeniorSecuredRevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:SeniorNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:SeniorNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">mtx:RedemptionOfNotesIfCompanyExperiencesChangeOfControlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:JapanLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:JapanLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mtx:ConceptPetHeimtierprodukteGmbhMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:AustriaAndSlovakiaTermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-29</startDate>
            <endDate>2022-04-29</endDate>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:AustriaAndSlovakiaTermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:AustriaAndSlovakiaTermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:AustriaAndSlovakiaTermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2027-01-01</startDate>
            <endDate>2027-12-31</endDate>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mtx:ConceptPetHeimtierprodukteGmbhMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:AustriaAndSlovakiaTermLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:UncommittedShortTermBankCreditLinesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:TermLoanDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:TermLoanDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:SeniorNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:SeniorNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:OtherDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mtx:OtherDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mtx:TalcRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-06-29</endDate>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mtx:TalcRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mtx:TalcRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mtx:TalcRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mtx:TalcRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mtx:TalcRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-30</instant>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:ConsumerAndSpecialtiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:ConsumerAndSpecialtiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:EngineeredSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mtx:EngineeredSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-05</instant>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:HouseholdAndPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:HouseholdAndPersonalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:SpecialtyAdditivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:SpecialtyAdditivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:HighTemperatureTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:HighTemperatureTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:EnvironmentalAndInfrastructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-04-05</endDate>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000891014</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mtx:EnvironmentalAndInfrastructureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Segment">
        <measure>mtx:Segment</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Quarter">
        <measure>mtx:Quarter</measure>
    </unit>
    <unit id="Loan">
        <measure>mtx:Loan</measure>
    </unit>
    <unit id="Claim">
        <measure>mtx:Claim</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-7396">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c0" id="ixv-23">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-7397">2026-04-05</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-7398">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-43">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-7399">1-11430</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-58">MINERALS TECHNOLOGIES INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-69">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-76">25-1190717</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-7400">622 Third Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-7401">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-7402">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-7403">10017-6707</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-7404">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-7405">878-1800</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0" id="ixv-130">Common Stock, $0.10 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0" id="ixv-134">MTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0" id="ixv-138">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-7406">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-7407">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-7408">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-208">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-214">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c0" id="ixv-245">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c1"
      decimals="INF"
      id="ixv-7409"
      unitRef="shares">31008734</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c0" decimals="-5" id="ixv-7410" unitRef="usd">546900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c2" decimals="-5" id="ixv-7411" unitRef="usd">491800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c0" decimals="-5" id="ixv-7412" unitRef="usd">415800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c2" decimals="-5" id="ixv-7413" unitRef="usd">372200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c0" decimals="-5" id="ixv-7414" unitRef="usd">131100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c2" decimals="-5" id="ixv-7415" unitRef="usd">119600000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c0" decimals="-5" id="ixv-7416" unitRef="usd">57500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c2" decimals="-5" id="ixv-7417" unitRef="usd">50600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-5" id="ixv-7418" unitRef="usd">6100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c2" decimals="-5" id="ixv-7419" unitRef="usd">5800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LossContingencyAccrualProvision contextRef="c0" decimals="-6" id="ixv-7420" unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision contextRef="c2" decimals="-5" id="ixv-7421" unitRef="usd">215000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:RestructuringCharges contextRef="c0" decimals="-6" id="ixv-7422" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c2" decimals="-5" id="ixv-7423" unitRef="usd">5500000</us-gaap:RestructuringCharges>
    <us-gaap:LitigationSettlementExpense contextRef="c0" decimals="-5" id="ixv-7424" unitRef="usd">8800000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c2" decimals="-5" id="ixv-7425" unitRef="usd">2800000</us-gaap:LitigationSettlementExpense>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-5" id="ixv-7426" unitRef="usd">58700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c2" decimals="-5" id="ixv-7427" unitRef="usd">-160100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c0" decimals="-5" id="ixv-7428" unitRef="usd">-13300000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c2" decimals="-5" id="ixv-7429" unitRef="usd">-14200000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c0" decimals="-5" id="ixv-7430" unitRef="usd">500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c2" decimals="-5" id="ixv-7431" unitRef="usd">-2000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c0" decimals="-5" id="ixv-7432" unitRef="usd">-12800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c2" decimals="-5" id="ixv-7433" unitRef="usd">-16200000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c0" decimals="-5" id="ixv-7434" unitRef="usd">45900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c2" decimals="-5" id="ixv-7435" unitRef="usd">-176300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-5" id="ixv-7436" unitRef="usd">9900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c2" decimals="-5" id="ixv-7437" unitRef="usd">-32100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c0" decimals="-5" id="ixv-7438" unitRef="usd">1300000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c2" decimals="-5" id="ixv-7439" unitRef="usd">1200000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss contextRef="c0" decimals="-5" id="ixv-7440" unitRef="usd">37300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c2" decimals="-5" id="ixv-7441" unitRef="usd">-143000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c0" decimals="-5" id="ixv-7442" unitRef="usd">1100000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c2" decimals="-5" id="ixv-7443" unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-5" id="ixv-7444" unitRef="usd">36200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c2" decimals="-5" id="ixv-7445" unitRef="usd">-144000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-7446"
      unitRef="usdPershares">1.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c2"
      decimals="2"
      id="ixv-7447"
      unitRef="usdPershares">-4.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-7448"
      unitRef="usdPershares">1.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c2"
      decimals="2"
      id="ixv-7449"
      unitRef="usdPershares">-4.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c0"
      decimals="INF"
      id="ixv-7450"
      unitRef="usdPershares">0.12</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c2"
      decimals="INF"
      id="ixv-7451"
      unitRef="usdPershares">0.11</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="-5"
      id="ixv-7452"
      unitRef="shares">31000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c2"
      decimals="-5"
      id="ixv-7453"
      unitRef="shares">31900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="-5"
      id="ixv-7454"
      unitRef="shares">31000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c2"
      decimals="-5"
      id="ixv-7455"
      unitRef="shares">31900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c0" decimals="-5" id="ixv-7456" unitRef="usd">37300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c2" decimals="-5" id="ixv-7457" unitRef="usd">-143000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c0" decimals="-5" id="ixv-7458" unitRef="usd">-13400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c2" decimals="-5" id="ixv-7459" unitRef="usd">9900000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c0" decimals="-6" id="ixv-7460" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c2" decimals="-5" id="ixv-7461" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c0" decimals="-5" id="ixv-7462" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c2" decimals="-5" id="ixv-7463" unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c0" decimals="-5" id="ixv-7464" unitRef="usd">-13300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c2" decimals="-5" id="ixv-7465" unitRef="usd">9700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c0" decimals="-5" id="ixv-7466" unitRef="usd">24000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c2" decimals="-5" id="ixv-7467" unitRef="usd">-133300000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c0" decimals="-5" id="ixv-7468" unitRef="usd">1000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c2" decimals="-5" id="ixv-7469" unitRef="usd">400000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="-5" id="ixv-7470" unitRef="usd">23000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c2" decimals="-5" id="ixv-7471" unitRef="usd">-133700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="-5" id="ix_0_fact" unitRef="usd">315900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="-5" id="ix_33_fact" unitRef="usd">329000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c3" decimals="-5" id="ix_1_fact" unitRef="usd">5400000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c4" decimals="-5" id="ix_34_fact" unitRef="usd">3600000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c3" decimals="-5" id="ix_2_fact" unitRef="usd">412700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c4" decimals="-5" id="ix_35_fact" unitRef="usd">400100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c3" decimals="-5" id="ix_3_fact" unitRef="usd">357900000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c4" decimals="-5" id="ix_36_fact" unitRef="usd">350200000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c3" decimals="-5" id="ix_4_fact" unitRef="usd">63600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c4" decimals="-5" id="ix_37_fact" unitRef="usd">72700000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="-5" id="ix_5_fact" unitRef="usd">1155500000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c4" decimals="-5" id="ix_38_fact" unitRef="usd">1155600000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c3" decimals="-5" id="ix_6_fact" unitRef="usd">2317400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c4" decimals="-5" id="ix_39_fact" unitRef="usd">2308900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c3" decimals="-5" id="ix_7_fact" unitRef="usd">1290800000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c4" decimals="-5" id="ix_40_fact" unitRef="usd">1283900000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-5" id="ix_8_fact" unitRef="usd">1026600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="-5" id="ix_41_fact" unitRef="usd">1025000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="c3" decimals="-5" id="ix_9_fact" unitRef="usd">915600000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c4" decimals="-5" id="ix_42_fact" unitRef="usd">915900000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c3" decimals="-5" id="ix_10_fact" unitRef="usd">205500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c4" decimals="-5" id="ix_43_fact" unitRef="usd">208700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c3" decimals="-5" id="ix_11_fact" unitRef="usd">15700000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c4" decimals="-5" id="ix_44_fact" unitRef="usd">15200000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c3" decimals="-5" id="ix_12_fact" unitRef="usd">146400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c4" decimals="-5" id="ix_45_fact" unitRef="usd">148600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c3" decimals="-5" id="ix_13_fact" unitRef="usd">3465300000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c4" decimals="-5" id="ix_46_fact" unitRef="usd">3469000000</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings contextRef="c3" decimals="-5" id="ix_14_fact" unitRef="usd">6000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c4" decimals="-5" id="ix_47_fact" unitRef="usd">400000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebtCurrent contextRef="c3" decimals="-5" id="ix_15_fact" unitRef="usd">6200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c4" decimals="-5" id="ix_48_fact" unitRef="usd">6300000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c3" decimals="-5" id="ix_16_fact" unitRef="usd">199700000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c4" decimals="-5" id="ix_49_fact" unitRef="usd">187900000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c3" decimals="-5" id="ix_17_fact" unitRef="usd">331500000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c4" decimals="-5" id="ix_50_fact" unitRef="usd">360800000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="-5" id="ix_18_fact" unitRef="usd">543400000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c4" decimals="-5" id="ix_51_fact" unitRef="usd">555400000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c3" decimals="-5" id="ix_19_fact" unitRef="usd">954000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c4" decimals="-5" id="ix_52_fact" unitRef="usd">955000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c3" decimals="-5" id="ix_20_fact" unitRef="usd">90800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c4" decimals="-5" id="ix_53_fact" unitRef="usd">90700000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c3" decimals="-5" id="ix_21_fact" unitRef="usd">16800000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c4" decimals="-5" id="ix_54_fact" unitRef="usd">19500000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c3" decimals="-5" id="ix_22_fact" unitRef="usd">98800000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c4" decimals="-5" id="ix_55_fact" unitRef="usd">98700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c3" decimals="-5" id="ix_23_fact" unitRef="usd">1703800000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c4" decimals="-5" id="ix_56_fact" unitRef="usd">1719300000</us-gaap:Liabilities>
    <us-gaap:CommonStockValue contextRef="c3" decimals="-5" id="ix_24_fact" unitRef="usd">5000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c4" decimals="-5" id="ix_57_fact" unitRef="usd">5000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c3" decimals="-5" id="ix_25_fact" unitRef="usd">535800000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c4" decimals="-5" id="ix_58_fact" unitRef="usd">535100000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="-5" id="ix_26_fact" unitRef="usd">2514400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="-5" id="ix_59_fact" unitRef="usd">2481900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c3" decimals="-5" id="ix_27_fact" unitRef="usd">-353500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c4" decimals="-5" id="ix_60_fact" unitRef="usd">-340400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonValue contextRef="c3" decimals="-5" id="ix_28_fact" unitRef="usd">973600000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c4" decimals="-5" id="ix_61_fact" unitRef="usd">968200000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-5" id="ix_29_fact" unitRef="usd">1728100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="-5" id="ix_62_fact" unitRef="usd">1713400000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c3" decimals="-5" id="ix_30_fact" unitRef="usd">33400000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c4" decimals="-5" id="ix_63_fact" unitRef="usd">36300000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c3" decimals="-5" id="ix_31_fact" unitRef="usd">1761500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c4" decimals="-5" id="ix_64_fact" unitRef="usd">1749700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="-5" id="ix_32_fact" unitRef="usd">3465300000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c4" decimals="-5" id="ix_65_fact" unitRef="usd">3469000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss contextRef="c0" decimals="-5" id="ixv-7540" unitRef="usd">37300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c2" decimals="-5" id="ixv-7541" unitRef="usd">-143000000</us-gaap:ProfitLoss>
    <us-gaap:CostDepreciationAmortizationAndDepletion contextRef="c0" decimals="-5" id="ixv-7542" unitRef="usd">24900000</us-gaap:CostDepreciationAmortizationAndDepletion>
    <us-gaap:CostDepreciationAmortizationAndDepletion contextRef="c2" decimals="-5" id="ixv-7543" unitRef="usd">23500000</us-gaap:CostDepreciationAmortizationAndDepletion>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c0" decimals="-5" id="ixv-7544" unitRef="usd">4100000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c2" decimals="-5" id="ixv-7545" unitRef="usd">3900000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:LossContingencyAccrualProvision contextRef="c0" decimals="-6" id="ixv-7546" unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision contextRef="c2" decimals="-5" id="ixv-7547" unitRef="usd">215000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:RestructuringCharges contextRef="c0" decimals="-6" id="ixv-7548" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c2" decimals="-5" id="ixv-7549" unitRef="usd">5500000</us-gaap:RestructuringCharges>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c0" decimals="-5" id="ixv-7550" unitRef="usd">-4400000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c2" decimals="-5" id="ixv-7551" unitRef="usd">39900000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInOperatingCapital contextRef="c0" decimals="-5" id="ixv-7552" unitRef="usd">38600000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital contextRef="c2" decimals="-5" id="ixv-7553" unitRef="usd">69400000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-5" id="ixv-7554" unitRef="usd">32100000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c2" decimals="-5" id="ixv-7555" unitRef="usd">-4400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-5" id="ixv-7556" unitRef="usd">23100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c2" decimals="-5" id="ixv-7557" unitRef="usd">18300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments contextRef="c0" decimals="-6" id="ixv-7558" unitRef="usd">0</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments contextRef="c2" decimals="-5" id="ixv-7559" unitRef="usd">3100000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c0" decimals="-5" id="ixv-7560" unitRef="usd">1300000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c2" decimals="-5" id="ixv-7561" unitRef="usd">4500000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c0" decimals="-5" id="ixv-7562" unitRef="usd">5000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c2" decimals="-5" id="ixv-7563" unitRef="usd">2100000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-5" id="ixv-7564" unitRef="usd">-29400000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c2" decimals="-5" id="ixv-7565" unitRef="usd">-21800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c0" decimals="-5" id="ixv-7566" unitRef="usd">5600000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="c2" decimals="-5" id="ixv-7567" unitRef="usd">14500000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c0" decimals="-5" id="ixv-7568" unitRef="usd">1500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c2" decimals="-6" id="ixv-7569" unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c0" decimals="-5" id="ixv-7570" unitRef="usd">5400000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c2" decimals="-5" id="ixv-7571" unitRef="usd">11500000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c0" decimals="-5" id="ixv-7572" unitRef="usd">1000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c2" decimals="-5" id="ixv-7573" unitRef="usd">100000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c0" decimals="-5" id="ixv-7574" unitRef="usd">3300000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c2" decimals="-5" id="ixv-7575" unitRef="usd">3400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="c0" decimals="-5" id="ixv-7576" unitRef="usd">3800000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="c2" decimals="-6" id="ixv-7577" unitRef="usd">0</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c0" decimals="-5" id="ixv-7578" unitRef="usd">3700000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c2" decimals="-5" id="ixv-7579" unitRef="usd">3600000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-5" id="ixv-7580" unitRef="usd">-11100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c2" decimals="-5" id="ixv-7581" unitRef="usd">-3900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c0" decimals="-5" id="ixv-7582" unitRef="usd">-4700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c2" decimals="-5" id="ixv-7583" unitRef="usd">3600000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="-5" id="ixv-7584" unitRef="usd">-13100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c2" decimals="-5" id="ixv-7585" unitRef="usd">-26500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c4" decimals="-5" id="ixv-7586" unitRef="usd">329000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="-5" id="ixv-7587" unitRef="usd">333100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" decimals="-5" id="ixv-7588" unitRef="usd">315900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c6" decimals="-5" id="ixv-7589" unitRef="usd">306600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c0" decimals="-5" id="ixv-7590" unitRef="usd">18900000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c2" decimals="-5" id="ixv-7591" unitRef="usd">19600000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c0" decimals="-5" id="ixv-7592" unitRef="usd">10900000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c2" decimals="-5" id="ixv-7593" unitRef="usd">9800000</us-gaap:IncomeTaxesPaidNet>
    <mtx:TreasuryStockPurchasesSettledAfterPeriodEnd contextRef="c0" decimals="-5" id="ixv-7594" unitRef="usd">100000</mtx:TreasuryStockPurchasesSettledAfterPeriodEnd>
    <mtx:TreasuryStockPurchasesSettledAfterPeriodEnd contextRef="c2" decimals="-5" id="ixv-7595" unitRef="usd">300000</mtx:TreasuryStockPurchasesSettledAfterPeriodEnd>
    <mtx:ExciseTaxChargedToEquityNotPaid contextRef="c0" decimals="-6" id="ixv-7596" unitRef="usd">0</mtx:ExciseTaxChargedToEquityNotPaid>
    <mtx:ExciseTaxChargedToEquityNotPaid contextRef="c2" decimals="-5" id="ixv-7597" unitRef="usd">100000</mtx:ExciseTaxChargedToEquityNotPaid>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c7" decimals="-5" id="ixv-7598" unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c8" decimals="-5" id="ixv-7599" unitRef="usd">535100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c9" decimals="-5" id="ixv-7600" unitRef="usd">2481900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c10" decimals="-5" id="ixv-7601" unitRef="usd">-340400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c11" decimals="-5" id="ixv-7602" unitRef="usd">-968200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c12" decimals="-5" id="ixv-7603" unitRef="usd">36300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c4" decimals="-5" id="ixv-7604" unitRef="usd">1749700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c13" decimals="-6" id="ixv-7605" unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c14" decimals="-6" id="ixv-7606" unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c15" decimals="-5" id="ixv-7607" unitRef="usd">36200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c16" decimals="-6" id="ixv-7608" unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c17" decimals="-6" id="ixv-7609" unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c18" decimals="-5" id="ixv-7610" unitRef="usd">1100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c0" decimals="-5" id="ixv-7611" unitRef="usd">37300000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c13" decimals="-6" id="ixv-7612" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c14" decimals="-6" id="ixv-7613" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c15" decimals="-6" id="ixv-7614" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c16" decimals="-5" id="ixv-7615" unitRef="usd">-13100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c17" decimals="-6" id="ixv-7616" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c18" decimals="-5" id="ixv-7617" unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c0" decimals="-5" id="ixv-7618" unitRef="usd">-13300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:Dividends contextRef="c13" decimals="-6" id="ixv-7619" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c14" decimals="-6" id="ixv-7620" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c15" decimals="-5" id="ixv-7621" unitRef="usd">3700000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c16" decimals="-6" id="ixv-7622" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c17" decimals="-6" id="ixv-7623" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c18" decimals="-6" id="ixv-7624" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c0" decimals="-5" id="ixv-7625" unitRef="usd">3700000</us-gaap:Dividends>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c13" decimals="-6" id="ixv-7626" unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c14" decimals="-6" id="ixv-7627" unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c15" decimals="-6" id="ixv-7628" unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c16" decimals="-6" id="ixv-7629" unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c17" decimals="-6" id="ixv-7630" unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c18" decimals="-5" id="ixv-7631" unitRef="usd">3800000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c0" decimals="-5" id="ixv-7632" unitRef="usd">3800000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c13" decimals="-6" id="ixv-7633" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c14" decimals="-5" id="ixv-7634" unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c15" decimals="-6" id="ixv-7635" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c16" decimals="-6" id="ixv-7636" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c17" decimals="-6" id="ixv-7637" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c18" decimals="-6" id="ixv-7638" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c0" decimals="-5" id="ixv-7639" unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c13" decimals="-6" id="ixv-7640" unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c14" decimals="-6" id="ixv-7641" unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c15" decimals="-6" id="ixv-7642" unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c16" decimals="-6" id="ixv-7643" unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c17" decimals="-5" id="ixv-7644" unitRef="usd">5400000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c18" decimals="-6" id="ixv-7645" unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c0" decimals="-5" id="ixv-7646" unitRef="usd">5400000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c13" decimals="-6" id="ixv-7647" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c14" decimals="-5" id="ixv-7648" unitRef="usd">3100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c15" decimals="-6" id="ixv-7649" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c16" decimals="-6" id="ixv-7650" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c17" decimals="-6" id="ixv-7651" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c18" decimals="-6" id="ixv-7652" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c0" decimals="-5" id="ixv-7653" unitRef="usd">3100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c13" decimals="-6" id="ixv-7654" unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c14" decimals="-5" id="ixv-7655" unitRef="usd">3400000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c15" decimals="-6" id="ixv-7656" unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c16" decimals="-6" id="ixv-7657" unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c17" decimals="-6" id="ixv-7658" unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c18" decimals="-6" id="ixv-7659" unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c0" decimals="-5" id="ixv-7660" unitRef="usd">3400000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c19" decimals="-5" id="ixv-7661" unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20" decimals="-5" id="ixv-7662" unitRef="usd">535800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c21" decimals="-5" id="ixv-7663" unitRef="usd">2514400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c22" decimals="-5" id="ixv-7664" unitRef="usd">-353500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c23" decimals="-5" id="ixv-7665" unitRef="usd">-973600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c24" decimals="-5" id="ixv-7666" unitRef="usd">33400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c3" decimals="-5" id="ixv-7667" unitRef="usd">1761500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c25" decimals="-5" id="ixv-7668" unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c26" decimals="-5" id="ixv-7669" unitRef="usd">523900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c27" decimals="-5" id="ixv-7670" unitRef="usd">2514500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c28" decimals="-5" id="ixv-7671" unitRef="usd">-387100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c29" decimals="-5" id="ixv-7672" unitRef="usd">-909300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c30" decimals="-5" id="ixv-7673" unitRef="usd">36200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c5" decimals="-5" id="ixv-7674" unitRef="usd">1783200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c31" decimals="-6" id="ixv-7675" unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c32" decimals="-6" id="ixv-7676" unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c33" decimals="-5" id="ixv-7677" unitRef="usd">-144000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c34" decimals="-6" id="ixv-7678" unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c35" decimals="-6" id="ixv-7679" unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c36" decimals="-5" id="ixv-7680" unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c2" decimals="-5" id="ixv-7681" unitRef="usd">-143000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c31" decimals="-6" id="ixv-7682" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c32" decimals="-6" id="ixv-7683" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c33" decimals="-6" id="ixv-7684" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c34" decimals="-5" id="ixv-7685" unitRef="usd">10300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c35" decimals="-6" id="ixv-7686" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c36" decimals="-5" id="ixv-7687" unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c2" decimals="-5" id="ixv-7688" unitRef="usd">9700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:Dividends contextRef="c31" decimals="-6" id="ixv-7689" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c32" decimals="-6" id="ixv-7690" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c33" decimals="-5" id="ixv-7691" unitRef="usd">3600000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c34" decimals="-6" id="ixv-7692" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c35" decimals="-6" id="ixv-7693" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c36" decimals="-6" id="ixv-7694" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c2" decimals="-5" id="ixv-7695" unitRef="usd">3600000</us-gaap:Dividends>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c31" decimals="-6" id="ixv-7696" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c32" decimals="-5" id="ixv-7697" unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c33" decimals="-6" id="ixv-7698" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c34" decimals="-6" id="ixv-7699" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c35" decimals="-6" id="ixv-7700" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c36" decimals="-6" id="ixv-7701" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="c2" decimals="-5" id="ixv-7702" unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c31" decimals="-6" id="ixv-7703" unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c32" decimals="-6" id="ixv-7704" unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c33" decimals="-6" id="ixv-7705" unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c34" decimals="-6" id="ixv-7706" unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c35" decimals="-5" id="ixv-7707" unitRef="usd">11500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c36" decimals="-6" id="ixv-7708" unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c2" decimals="-5" id="ixv-7709" unitRef="usd">11500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c31" decimals="-6" id="ixv-7710" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c32" decimals="-5" id="ixv-7711" unitRef="usd">3000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c33" decimals="-6" id="ixv-7712" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c34" decimals="-6" id="ixv-7713" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c35" decimals="-6" id="ixv-7714" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c36" decimals="-6" id="ixv-7715" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c2" decimals="-5" id="ixv-7716" unitRef="usd">3000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c31" decimals="-6" id="ixv-7717" unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c32" decimals="-5" id="ixv-7718" unitRef="usd">3100000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c33" decimals="-6" id="ixv-7719" unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c34" decimals="-6" id="ixv-7720" unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c35" decimals="-6" id="ixv-7721" unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c36" decimals="-6" id="ixv-7722" unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c2" decimals="-5" id="ixv-7723" unitRef="usd">3100000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c37" decimals="-5" id="ixv-7724" unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c38" decimals="-5" id="ixv-7725" unitRef="usd">523900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c39" decimals="-5" id="ixv-7726" unitRef="usd">2366900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c40" decimals="-5" id="ixv-7727" unitRef="usd">-376800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c41" decimals="-5" id="ixv-7728" unitRef="usd">-920800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c42" decimals="-5" id="ixv-7729" unitRef="usd">36600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c6" decimals="-5" id="ixv-7730" unitRef="usd">1634800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-2953">&lt;div&gt;
   &lt;span style="font-weight: bold;"&gt;Note 1.&#160;&#160;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;

  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   The accompanying unaudited Condensed Consolidated Financial Statements have been prepared by management of Minerals Technologies Inc. (together with its subsidiaries, the &#x201c;Company,&#x201d; &#x201c;MTI,&#x201d; &#x201c;we,&#x201d;&#160;&lt;span style="letter-spacing: normal; text-indent: 48px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"&gt;&#x201c;us,&#x201d;&lt;/span&gt; or &#x201c;our&#x201d;) in accordance with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025. In the opinion of management, all adjustments, consisting solely of normal recurring adjustments necessary for a fair presentation of the financial information for the periods indicated, have been included. The results for the three-month period ended April 5, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2026.
  &lt;/div&gt;&lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;
   &lt;span style="font-weight: bold;"&gt;Company Operations&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span style="color: #000000;"&gt;The Company is a global, technology-driven specialty minerals company that develops, produces, and markets a wide range of minerals and mineral-based products and services.&#160;We utilize global mineral reserves with our core technologies and applications to deliver innovative solutions for products that are part of everyday life.&#160; We serve customers in consumer and industrial markets worldwide.&lt;/span&gt;&lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The Company has two reportable segments: Consumer &amp;amp; Specialties and Engineered Solutions.&lt;/span&gt; &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;ul style="list-style-type: disc; padding: 0; margin: 0;"&gt;
    &lt;li style="line-height: 12.95pt; text-align: justify; margin-left: 36pt; font-family: Calibri;"&gt;
     &lt;span style="font-family: Times New Roman; font-size: 10.0pt;"&gt;The Consumer &amp;amp; Specialties segment serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of our customers' finished products.&lt;/span&gt;&lt;/li&gt;
    &lt;/ul&gt;
&lt;div style="line-height: 12.95pt; text-align: justify; margin-left: 36pt; font-family: Calibri;"&gt;&#160;
    &lt;/div&gt;
&lt;ul style="list-style-type: disc; padding: 0; margin: 0;"&gt;
    &lt;li style="line-height: 12.95pt; text-align: justify; margin-left: 36pt; font-family: Calibri;"&gt;
     &lt;span style="font-family: Times New Roman; font-size: 10.0pt;"&gt;The &lt;/span&gt;&lt;span style="font-family: Times New Roman; font-size: 10.0pt; color: #000000;"&gt;Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve our customers' manufacturing processes and projects.&lt;/span&gt;&lt;/li&gt;
  &lt;/ul&gt;
  &lt;div style="line-height: 12.95pt; text-align: justify; margin-left: 36pt; font-family: Calibri;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: -4.5pt; padding-left: 40.5pt;"&gt; &lt;span style="font-style: italic;"&gt;Use of Estimates&lt;/span&gt; &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;The Company employs accounting policies that are in accordance with U.S. generally accepted accounting principles and require management to make estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reported period. Significant estimates include those related to revenue recognition, valuation of long-lived assets, goodwill and other intangible assets, certain pension plan assumptions, valuation of deferred income tax assets,  provision for credit losses, and legal and environmental liabilities. Actual results could differ from those estimates.&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span style="font-style: italic;"&gt;Reclassifications&lt;/span&gt; &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;Certain reclassifications have been made to the prior period financial information to conform to the presentation used in the Condensed Consolidated Financial Statements for the three-month periods ended April 5, 2026.&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;

  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span style="font-style: italic;"&gt;Recently Issued Accounting Standards&lt;/span&gt; &lt;/div&gt;&lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;Changes to accounting principles generally accepted in the United States of America (U.S. GAAP) are established by the Financial Accounting Standards Board (FASB) in the form of accounting standards updates (ASUs) to the FASB&#x2019;s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on our consolidated financial position and results of operations.&lt;/span&gt;
  &lt;/div&gt;&lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;i&gt;&lt;span style="font-size:10.0pt"&gt;Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;
  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Income
Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures
(Subtopic 220-40):&#160;&#160;Disaggregation of Income Statement Expenses&#x201d; that
requires entities to disclose additional information in the notes to the
financial statements about prescribed categories underlying any relevant income
statement expense caption.&#160;The new standard is effective for annual
reporting periods beginning after December 15, 2026, and interim periods within
annual reporting periods beginning after December 15, 2027.&#160;The adoption
of this standard is not expected to have a material impact on the Company&#x2019;s
Consolidated Financial Statements but will result in disaggregation of the
Company's income statement expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c0"
      decimals="INF"
      id="ixv-7731"
      unitRef="Segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-2978">&lt;div style="text-indent: -4.5pt; padding-left: 40.5pt;"&gt; &lt;span style="font-style: italic;"&gt;Use of Estimates&lt;/span&gt; &lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;The Company employs accounting policies that are in accordance with U.S. generally accepted accounting principles and require management to make estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reported period. Significant estimates include those related to revenue recognition, valuation of long-lived assets, goodwill and other intangible assets, certain pension plan assumptions, valuation of deferred income tax assets,  provision for credit losses, and legal and environmental liabilities. Actual results could differ from those estimates.&lt;/span&gt;
  &lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c0" id="ixv-2986">&lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span style="font-style: italic;"&gt;Reclassifications&lt;/span&gt; &lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;Certain reclassifications have been made to the prior period financial information to conform to the presentation used in the Condensed Consolidated Financial Statements for the three-month periods ended April 5, 2026.&lt;/span&gt;
  &lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0" id="ixv-2994">&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span style="font-style: italic;"&gt;Recently Issued Accounting Standards&lt;/span&gt; &lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;Changes to accounting principles generally accepted in the United States of America (U.S. GAAP) are established by the Financial Accounting Standards Board (FASB) in the form of accounting standards updates (ASUs) to the FASB&#x2019;s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on our consolidated financial position and results of operations.&lt;/span&gt;
  &lt;/div&gt;&lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;i&gt;&lt;span style="font-size:10.0pt"&gt;Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;/i&gt;&lt;/div&gt;&lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Income
Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures
(Subtopic 220-40):&#160;&#160;Disaggregation of Income Statement Expenses&#x201d; that
requires entities to disclose additional information in the notes to the
financial statements about prescribed categories underlying any relevant income
statement expense caption.&#160;The new standard is effective for annual
reporting periods beginning after December 15, 2026, and interim periods within
annual reporting periods beginning after December 15, 2027.&#160;The adoption
of this standard is not expected to have a material impact on the Company&#x2019;s
Consolidated Financial Statements but will result in disaggregation of the
Company's income statement expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c0" id="ixv-3028">&lt;div&gt;
   &lt;span style="font-weight: bold;"&gt;Note 2.&#160;&#160;Revenue from Contracts with Customers&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The following table disaggregates our revenue by major source (product line) for the three-month periods ended April 5, 2026 and March 30, 2025:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;&lt;/td&gt;&lt;td colspan="1" style="text-align: center; font-weight: bold; border-width: initial; border-style: none; border-color: initial;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C2"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C2"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;Net Sales&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="REVENUE - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="REVENUE - C3"&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;"&gt;&#160;&lt;/td&gt;&lt;td title="REVENUE - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;2025&lt;/td&gt;&lt;td title="REVENUE - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Household &amp;amp; Personal Care &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C3"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;142.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E3"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;123.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Specialty Additives&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - C4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;154.2&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - E4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;145.2&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold;"&gt;Consumer &amp;amp; Specialties Segment&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - C4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;296.6&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - E4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;268.3&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; text-indent: -10px; padding-left: 10px;"&gt;&lt;/td&gt;&lt;td title="REVENUE - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="REVENUE - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="REVENUE - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="REVENUE - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;High-Temperature Technologies&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;183.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;169.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;Environmental &amp;amp; Infrastructure&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;67.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;54.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="text-indent: -10px; padding-left: 10px; font-weight: bold;"&gt;Engineered Solutions Segment&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;" title="REVENUE - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;"&gt;250.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;" title="REVENUE - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;" title="REVENUE - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;"&gt;223.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;" title="REVENUE - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C9"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C9"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - E9"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - E9"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;          Total net sales&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;" title="REVENUE - C10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;"&gt;546.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;" title="REVENUE - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;" title="REVENUE - E10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;"&gt;491.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;" title="REVENUE - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c0" id="ixv-3032">&lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The following table disaggregates our revenue by major source (product line) for the three-month periods ended April 5, 2026 and March 30, 2025:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;&lt;/td&gt;&lt;td colspan="1" style="text-align: center; font-weight: bold; border-width: initial; border-style: none; border-color: initial;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C2"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C2"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;Net Sales&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="REVENUE - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="REVENUE - C3"&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;"&gt;&#160;&lt;/td&gt;&lt;td title="REVENUE - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;2025&lt;/td&gt;&lt;td title="REVENUE - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Household &amp;amp; Personal Care &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C3"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;142.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C3"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E3"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;123.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Specialty Additives&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - C4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;154.2&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - E4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;145.2&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold;"&gt;Consumer &amp;amp; Specialties Segment&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - C4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;296.6&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - E4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;268.3&lt;/td&gt;&lt;td style="border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%; text-align: left;" title="REVENUE - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; text-indent: -10px; padding-left: 10px;"&gt;&lt;/td&gt;&lt;td title="REVENUE - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="REVENUE - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="REVENUE - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="REVENUE - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;High-Temperature Technologies&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;183.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;169.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;Environmental &amp;amp; Infrastructure&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;67.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;54.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="REVENUE - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="text-indent: -10px; padding-left: 10px; font-weight: bold;"&gt;Engineered Solutions Segment&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;" title="REVENUE - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;"&gt;250.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;" title="REVENUE - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;" title="REVENUE - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;"&gt;223.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: none; border-top: 1px solid rgb(0, 0, 0); border-left: none; border-right: none;" title="REVENUE - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C9"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - C9"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - E9"&gt;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: 1px medium medium; border-style: solid none none; border-color: rgb(0, 0, 0) currentcolor currentcolor;" title="REVENUE - E9"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;          Total net sales&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;" title="REVENUE - C10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;"&gt;546.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;" title="REVENUE - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;" title="REVENUE - E10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;"&gt;491.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;" title="REVENUE - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c43" decimals="-5" id="ixv-7732" unitRef="usd">142400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c44" decimals="-5" id="ixv-7733" unitRef="usd">123100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c45" decimals="-5" id="ixv-7734" unitRef="usd">154200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c46" decimals="-5" id="ixv-7735" unitRef="usd">145200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c47" decimals="-5" id="ixv-7736" unitRef="usd">296600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c48" decimals="-5" id="ixv-7737" unitRef="usd">268300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c49" decimals="-5" id="ixv-7738" unitRef="usd">183300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c50" decimals="-5" id="ixv-7739" unitRef="usd">169400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c51" decimals="-5" id="ixv-7740" unitRef="usd">67000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c52" decimals="-5" id="ixv-7741" unitRef="usd">54100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c53" decimals="-5" id="ixv-7742" unitRef="usd">250300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c54" decimals="-5" id="ixv-7743" unitRef="usd">223500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c0" decimals="-5" id="ixv-7744" unitRef="usd">546900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c2" decimals="-5" id="ixv-7745" unitRef="usd">491800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:EarningsPerShareTextBlock contextRef="c0" id="ixv-3158">&lt;div style="text-indent: -45.1pt; text-align: justify; padding-left: 45.1pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 3.&#160;&#160;Earnings (loss) per Share (EPS)&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;Basic earnings (loss) per share are based upon the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are based upon the weighted average number of common shares outstanding during the period, assuming the issuance of common shares for all potentially dilutive common shares outstanding.&lt;/span&gt;
  &lt;/div&gt;







  &lt;div style="text-indent: 36pt;"&gt;&#160;&lt;/div&gt;&lt;div style="text-indent: 36pt; font-size: 10pt;"&gt;The following table sets forth the computation of basic and diluted earnings (loss) per share: &lt;/div&gt;&lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars, except per share data)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="EPS - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="EPS - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="EPS - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="EPS - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; text-indent: -10px; padding-left: 10px;"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="EPS - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="EPS - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="EPS - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="EPS - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; text-indent: -10px; padding-left: 10px;"&gt;Net income (loss) attributable to Minerals Technologies Inc.&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;" title="EPS - C5"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;"&gt;36.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;" title="EPS - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;" title="EPS - E5"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;"&gt;(144.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;" title="EPS - E5"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C6"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C6"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E6"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E6"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;Weighted average shares outstanding &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="EPS - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;31.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="EPS - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="EPS - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;31.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="EPS - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;Dilutive effect of stock options and deferred restricted stock units &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="EPS - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="EPS - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="EPS - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="EPS - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;     Weighted average shares outstanding, adjusted &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-left: none; border-right: none; border-bottom: 3px double black;" title="EPS - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;"&gt;31.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="EPS - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="EPS - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;"&gt;31.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="EPS - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C10"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C10"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E10"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E10"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; text-indent: -10px; padding-left: 10px;"&gt;Basic earnings (loss) per share attributable to Minerals Technologies Inc.&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-left: none; border-right: none; border-bottom: 3px double black; vertical-align: bottom;" title="EPS - C11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none; vertical-align: bottom;"&gt;1.17&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none; vertical-align: bottom;" title="EPS - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none; vertical-align: bottom;" title="EPS - E11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none; vertical-align: bottom;"&gt;(4.51&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none; vertical-align: bottom;" title="EPS - E11"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C12"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C12"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E12"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E12"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; text-indent: -10px; padding-left: 10px;"&gt;Diluted earnings (loss) per share attributable to Minerals Technologies Inc.&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="EPS - C13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;"&gt;1.17&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="EPS - C13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="EPS - E13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;"&gt;(4.51&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="EPS - E13"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;Of the options outstanding of 1,678,847 and 1,596,748 for the three-month periods ended April 5, 2026 and March 30, 2025, respectively, options to purchase 943,056 shares and &lt;span style="letter-spacing: normal; text-indent: 48px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"&gt;1,596,748&lt;/span&gt; shares of common stock for the three-month periods ending April 5, 2026 and March 30, 2025, respectively, were not included in the computation of diluted earnings (loss) per share because they were anti-dilutive, as the exercise prices of the options were greater than the average market price of the common shares. Due to our net loss for the three-month period ending March 30, 2025, all options to purchase shares were anti-dilutive and were excluded for this period.&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0" id="ixv-3165">&lt;div style="text-indent: 36pt; font-size: 10pt;"&gt;The following table sets forth the computation of basic and diluted earnings (loss) per share: &lt;/div&gt;&lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars, except per share data)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="EPS - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="EPS - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="EPS - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="EPS - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; text-indent: -10px; padding-left: 10px;"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="EPS - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="EPS - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="EPS - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="EPS - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; text-indent: -10px; padding-left: 10px;"&gt;Net income (loss) attributable to Minerals Technologies Inc.&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;" title="EPS - C5"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;"&gt;36.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;" title="EPS - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;" title="EPS - E5"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;"&gt;(144.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-right: none; border-bottom: 3px double black; border-left: none;" title="EPS - E5"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C6"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C6"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E6"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E6"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;Weighted average shares outstanding &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="EPS - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;31.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="EPS - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="EPS - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;31.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="EPS - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;Dilutive effect of stock options and deferred restricted stock units &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="EPS - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="EPS - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="EPS - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="EPS - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;     Weighted average shares outstanding, adjusted &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-left: none; border-right: none; border-bottom: 3px double black;" title="EPS - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;"&gt;31.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="EPS - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="EPS - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;"&gt;31.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="EPS - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C10"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C10"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E10"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E10"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; text-indent: -10px; padding-left: 10px;"&gt;Basic earnings (loss) per share attributable to Minerals Technologies Inc.&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-left: none; border-right: none; border-bottom: 3px double black; vertical-align: bottom;" title="EPS - C11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none; vertical-align: bottom;"&gt;1.17&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none; vertical-align: bottom;" title="EPS - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none; vertical-align: bottom;" title="EPS - E11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none; vertical-align: bottom;"&gt;(4.51&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none; vertical-align: bottom;" title="EPS - E11"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C12"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - C12"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E12"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="EPS - E12"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; text-indent: -10px; padding-left: 10px;"&gt;Diluted earnings (loss) per share attributable to Minerals Technologies Inc.&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="EPS - C13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;"&gt;1.17&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="EPS - C13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="EPS - E13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;"&gt;(4.51&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="EPS - E13"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-5" id="ixv-7746" unitRef="usd">36200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c2" decimals="-5" id="ixv-7747" unitRef="usd">-144000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="-5"
      id="ixv-7748"
      unitRef="shares">31000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c2"
      decimals="-5"
      id="ixv-7749"
      unitRef="shares">31900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="c0"
      decimals="-6"
      id="ixv-7750"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="c2"
      decimals="-6"
      id="ixv-7751"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="-5"
      id="ixv-7752"
      unitRef="shares">31000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c2"
      decimals="-5"
      id="ixv-7753"
      unitRef="shares">31900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-7754"
      unitRef="usdPershares">1.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c2"
      decimals="2"
      id="ixv-7755"
      unitRef="usdPershares">-4.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-7756"
      unitRef="usdPershares">1.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c2"
      decimals="2"
      id="ixv-7757"
      unitRef="usdPershares">-4.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="c55"
      decimals="INF"
      id="ixv-7758"
      unitRef="shares">1678847</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="c56"
      decimals="INF"
      id="ixv-7759"
      unitRef="shares">1596748</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c57"
      decimals="INF"
      id="ixv-7760"
      unitRef="shares">943056</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c58"
      decimals="INF"
      id="ixv-7761"
      unitRef="shares">1596748</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="c0" id="ixv-3310">&lt;div style="text-indent: -45.1pt; text-align: justify; padding-left: 45.1pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 4.&#160;&#160;Restructuring and Other Items&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;


  &lt;div style="text-indent: 36pt; text-align: justify; font-size: 10pt;"&gt; In the first quarter of 2025, the Company initiated a cost savings program, primarily through workforce reductions, and recorded a charge of $5.5 million for severance and other related costs associated with this program. &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify; font-size: 10pt;"&gt; The following table outlines the amount of restructuring charges recorded within the Condensed Consolidated Statements of Income (Loss) and the segment they relate to: &lt;/div&gt;



  &lt;div style="text-align: justify;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; margin-left: 0px; margin-right: 0px; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="RESTR - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Apr. 5,&lt;/td&gt;&lt;td title="RESTR - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="RESTR - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Mar. 30,&lt;/td&gt;&lt;td title="RESTR - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="RESTR - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="RESTR - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="RESTR - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="RESTR - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-style: italic;"&gt;Severance and other related costs&lt;/td&gt;&lt;td title="RESTR - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="RESTR - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="RESTR - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="RESTR - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;     Consumer &amp;amp; Specialties&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - C5"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - E5"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;     Engineered Solutions&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="text-align: left; vertical-align: bottom;"&gt;     Corporate&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;Total restructuring and other items&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - C7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - E7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;5.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align: justify;"&gt;&#160;&lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span style="font-size: 9.5pt;"&gt;At April 5, 2026, the Company had $4.3 million included within other current liabilities in the Condensed Consolidated Balance Sheet for cash expenditures needed to satisfy remaining obligations under workforce reduction initiatives. The Company expects to pay these amounts within the next twelve months.&lt;/span&gt; &lt;/div&gt;&lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span style="font-size: 9.5pt;"&gt;The following table is a reconciliation of our restructuring liability balance relating to workforce reductions as of April 5, 2026:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C2"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C2"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Restructuring liability, December 31, 2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;4.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Cash payments&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;(0.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Restructuring liability, April 5, 2026&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;4.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCharges contextRef="c2" decimals="-5" id="ixv-7762" unitRef="usd">5500000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="c0" id="ixv-3316">&lt;div style="text-indent: 36pt; text-align: justify; font-size: 10pt;"&gt; The following table outlines the amount of restructuring charges recorded within the Condensed Consolidated Statements of Income (Loss) and the segment they relate to: &lt;/div&gt;



  &lt;div style="text-align: justify;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; margin-left: 0px; margin-right: 0px; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="RESTR - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Apr. 5,&lt;/td&gt;&lt;td title="RESTR - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="RESTR - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Mar. 30,&lt;/td&gt;&lt;td title="RESTR - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="RESTR - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="RESTR - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="RESTR - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="RESTR - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-style: italic;"&gt;Severance and other related costs&lt;/td&gt;&lt;td title="RESTR - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="RESTR - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="RESTR - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="RESTR - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;     Consumer &amp;amp; Specialties&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - C5"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - E5"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;     Engineered Solutions&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="RESTR - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="text-align: left; vertical-align: bottom;"&gt;     Corporate&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;Total restructuring and other items&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - C7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - E7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;5.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="RESTR - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCharges contextRef="c60" decimals="-6" id="ixv-7763" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c61" decimals="-5" id="ixv-7764" unitRef="usd">2500000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c62" decimals="-6" id="ixv-7765" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c63" decimals="-5" id="ixv-7766" unitRef="usd">800000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c64" decimals="-6" id="ixv-7767" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c65" decimals="-5" id="ixv-7768" unitRef="usd">2200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c0" decimals="-6" id="ixv-7769" unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c2" decimals="-5" id="ixv-7770" unitRef="usd">5500000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveCurrent contextRef="c59" decimals="-5" id="ixv-7771" unitRef="usd">4300000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="c0" id="ixv-3408">&lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span style="font-size: 9.5pt;"&gt;The following table is a reconciliation of our restructuring liability balance relating to workforce reductions as of April 5, 2026:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C2"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C2"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Restructuring liability, December 31, 2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;4.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Cash payments&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;(0.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Restructuring liability, April 5, 2026&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;4.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="Restr rollforward - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve contextRef="c4" decimals="-5" id="ixv-7772" unitRef="usd">4900000</us-gaap:RestructuringReserve>
    <us-gaap:PaymentsForRestructuring contextRef="c0" decimals="-5" id="ixv-7773" unitRef="usd">600000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c3" decimals="-5" id="ixv-7774" unitRef="usd">4300000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0" id="ixv-3439">&lt;div&gt;
   &lt;span style="font-weight: bold;"&gt;Note 5.&#160;&#160;Income Taxes&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;

  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span style="font-size: 9.5pt;"&gt;&lt;span style="letter-spacing: normal; text-indent: 48px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"&gt;Provision (benefit) for taxes was $9.9&#160;million and $(32.1)&#160;million during the&#160;three-month&#160;periods ended April 5, 2026 and March 30, 2025.&#160;&lt;/span&gt;The benefit from taxes for the three-month period ended March 30, 2025 relates to pre-tax losses, primarily as a result of the provision for litigation accrual and credit losses recorded in the first quarter of 2025. The effective tax rate was 21.5% for the three-month period ended April 5, 2026, as compared with 18.2% for the three-month period ended March 30, 2025. The lower rate in the previous year was primarily due to the provision for the litigation accrual and credit losses and the mixture of earnings. &lt;/span&gt; &lt;/div&gt;&lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify; font-size: 10pt;"&gt; As of April 5, 2026, the Company had approximately $5.8 million of total unrecognized income tax benefits. Included in this amount were a total of $4.4 million of unrecognized income tax benefits that, if recognized, would affect the Company&#x2019;s effective tax rate. While it is expected that the amount of unrecognized tax benefits will change in the next 12 months, the Company does not expect the change to have a significant impact on the results of operations or the financial position of the Company. &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The Company&#x2019;s accounting policy is to recognize interest and penalties accrued, relating to unrecognized income tax or benefit as part of its provision for income taxes. The Company had a net addition of approximately $0.4 million during the three-month period ended April 5, 2026 and had an accrued balance of $0.7 million of interest and penalties as of April 5, 2026. &lt;/span&gt; &lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;The Company operates in multiple taxing jurisdictions, both within and outside the U.S.  In certain situations, a taxing authority may challenge positions that the Company has adopted in its income tax filings. The Company, with a few exceptions (none of which are material), is no longer subject to U.S. federal, state, local, and international income tax examinations by tax authorities for years prior to 2017.&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;On July 4, 2025, the One Big Beautiful Bill Act was signed into law in the U.S. It contains a broad range of tax reform provisions affecting businesses.&#160;The Company evaluated the full effects of the legislation on our annual effective tax rate and cash tax position, and it did not have a material impact on our Consolidated Financial Statements. &lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;In December 2021, the Organization for Economic Co-operation and Development (&#x201c;OECD&#x201d;) released the Pillar Two Model Rules which aim to reform international corporate taxation rules, including the implementation of a global minimum tax rate. The Company began implementation of the Pillar Two Model Rules in the first quarter of 2024. The Company continues to assess the effect of the Pillar Two Model Rules in all jurisdictions and does not expect that Pillar Two will have a material impact on its Consolidated Financial Statements.&lt;/span&gt;
  &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-5" id="ixv-7775" unitRef="usd">9900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c2" decimals="-5" id="ixv-7776" unitRef="usd">-32100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c0" decimals="3" id="ixv-7777" unitRef="pure">0.215</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c2" decimals="3" id="ixv-7778" unitRef="pure">0.182</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c3" decimals="-5" id="ixv-7779" unitRef="usd">5800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c3" decimals="-5" id="ixv-7780" unitRef="usd">4400000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c0" decimals="-5" id="ixv-7781" unitRef="usd">400000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c3" decimals="-5" id="ixv-7782" unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c0" id="ixv-3481">&lt;div&gt;&lt;span style="font-weight: bold;"&gt;Note 6.&#160;&#160;Inventories&lt;/span&gt;
  &lt;/div&gt;&lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt;"&gt; &lt;span&gt;The following is a summary of inventories by major category:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C2"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C2"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E2"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Dec. 31,&lt;/td&gt;&lt;td style="width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E2"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Raw materials &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;163.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;160.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Work-in-process &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;11.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;13.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Finished goods &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;121.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;117.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Packaging and supplies&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;61.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;59.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;Total inventories &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;357.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;350.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c0" id="ixv-3485">&lt;div style="text-indent: 36pt;"&gt; &lt;span&gt;The following is a summary of inventories by major category:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C2"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C2"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E2"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Dec. 31,&lt;/td&gt;&lt;td style="width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E2"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Raw materials &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;163.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;160.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Work-in-process &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;11.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;13.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Finished goods &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;121.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;117.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Packaging and supplies&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;61.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;59.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;Total inventories &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;357.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;350.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INVY - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c3" decimals="-5" id="ixv-7783" unitRef="usd">163800000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c4" decimals="-5" id="ixv-7784" unitRef="usd">160600000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c3" decimals="-5" id="ixv-7785" unitRef="usd">11200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c4" decimals="-5" id="ixv-7786" unitRef="usd">13300000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c3" decimals="-5" id="ixv-7787" unitRef="usd">121800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c4" decimals="-5" id="ixv-7788" unitRef="usd">117300000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventorySuppliesNetOfReserves contextRef="c3" decimals="-5" id="ixv-7789" unitRef="usd">61100000</us-gaap:InventorySuppliesNetOfReserves>
    <us-gaap:InventorySuppliesNetOfReserves contextRef="c4" decimals="-5" id="ixv-7790" unitRef="usd">59000000</us-gaap:InventorySuppliesNetOfReserves>
    <us-gaap:InventoryNet contextRef="c3" decimals="-5" id="ixv-7791" unitRef="usd">357900000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c4" decimals="-5" id="ixv-7792" unitRef="usd">350200000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c0" id="ixv-3563">&lt;div&gt;
   &lt;span style="font-weight: bold;"&gt;Note 7.&#160;&#160;Goodwill and Other Intangible Assets&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;Goodwill and other intangible assets with indefinite lives are not amortized, but instead are assessed for impairment, at least annually. The carrying amount of goodwill was $915.6 million and $915.9 million as of April 5, 2026 and December 31, 2025, respectively. The net change in goodwill from December 31, 2025 to April 5, 2026 is attributable to the effects of foreign exchange. &lt;/span&gt; &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;Acquired intangible assets subject to amortization as of April 5, 2026 and December 31, 2025 were as follows:&lt;/span&gt; &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;


  &lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="text-align: center; width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C2"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C2"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Apr. 5, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Dec. 31, 2025&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C3"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; white-space: nowrap; width: 9%;"&gt;Weighted Average&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Gross&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - E3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - G3"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - G3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - I3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Gross&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - I3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - K3"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - K3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; white-space: nowrap; width: 9%;"&gt;Useful Life&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Carrying&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - E4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - G4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Accumulated&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - G4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - I4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Carrying&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - I4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - K4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Accumulated&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - K4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - C5"&gt;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; font-weight: bold; text-align: center; width: 9%;"&gt;(Years)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - E5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;Amount&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - G5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;Amortization&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - G5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - I5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;Amount&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - I5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - K5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;Amortization&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - K5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Tradenames&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;34&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;221.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;68.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;221.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;67.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Technology&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;18.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;15.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;18.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;15.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Patents and trademarks&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;19&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Customer relationships&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; text-align: right;"&gt;21&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;79.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - E9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - G9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;30.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - G9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - I9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;80.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - I9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - K9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;28.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - K9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;29&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - E10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;326.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - E10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - G10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;121.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - G10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - I10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;327.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - I10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - K10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;118.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - K10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&#160;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The weighted average amortization period for acquired intangible assets subject to amortization is approximately 29 years. Estimated amortization expense is $8.6 million for the remainder of 2026, $46.0 million for 2027&#x2013;2030 and $150.9 million thereafter.&lt;/span&gt; &lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill contextRef="c3" decimals="-5" id="ixv-7793" unitRef="usd">915600000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c4" decimals="-5" id="ixv-7794" unitRef="usd">915900000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock contextRef="c0" id="ixv-3570">&lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;Acquired intangible assets subject to amortization as of April 5, 2026 and December 31, 2025 were as follows:&lt;/span&gt; &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;


  &lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="text-align: center; width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C2"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C2"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Apr. 5, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Dec. 31, 2025&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C3"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; white-space: nowrap; width: 9%;"&gt;Weighted Average&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Gross&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - E3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - G3"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - G3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - I3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Gross&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - I3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - K3"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - K3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; white-space: nowrap; width: 9%;"&gt;Useful Life&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Carrying&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - E4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - G4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Accumulated&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - G4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - I4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Carrying&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - I4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - K4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Accumulated&lt;/td&gt;&lt;td style="width: 1%;" title="INTANG - K4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - C5"&gt;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; font-weight: bold; text-align: center; width: 9%;"&gt;(Years)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - E5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;Amount&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - G5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;Amortization&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - G5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - I5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;Amount&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - I5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - K5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;Amortization&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="INTANG - K5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Tradenames&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;34&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;221.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;68.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;221.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;67.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Technology&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;18.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;15.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;18.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;15.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Patents and trademarks&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;19&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - E8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - G8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - I8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - K8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Customer relationships&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; text-align: right;"&gt;21&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;79.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - E9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - G9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;30.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - G9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - I9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;80.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - I9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - K9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;28.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="INTANG - K9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;29&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="INTANG - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - E10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;326.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - E10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - G10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;121.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - G10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - I10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;327.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - I10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - K10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;118.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="INTANG - K10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c66" id="ixv-7795">P34Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c66" decimals="-5" id="ixv-7796" unitRef="usd">221400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c66" decimals="-5" id="ixv-7797" unitRef="usd">68500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c67" decimals="-5" id="ixv-7798" unitRef="usd">221400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c67" decimals="-5" id="ixv-7799" unitRef="usd">67600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c68" id="ixv-7800">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c68" decimals="-5" id="ixv-7801" unitRef="usd">18800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c68" decimals="-5" id="ixv-7802" unitRef="usd">15600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c69" decimals="-5" id="ixv-7803" unitRef="usd">18800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c69" decimals="-5" id="ixv-7804" unitRef="usd">15500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c70" id="ixv-7805">P19Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c70" decimals="-5" id="ixv-7806" unitRef="usd">6400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c70" decimals="-5" id="ixv-7807" unitRef="usd">6400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c71" decimals="-5" id="ixv-7808" unitRef="usd">6400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c71" decimals="-5" id="ixv-7809" unitRef="usd">6400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c72" id="ixv-7810">P21Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c72" decimals="-5" id="ixv-7811" unitRef="usd">79900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c72" decimals="-5" id="ixv-7812" unitRef="usd">30500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c73" decimals="-5" id="ixv-7813" unitRef="usd">80400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c73" decimals="-5" id="ixv-7814" unitRef="usd">28800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c3" id="ixv-7815">P29Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c3" decimals="-5" id="ixv-7816" unitRef="usd">326500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c3" decimals="-5" id="ixv-7817" unitRef="usd">121000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c4" decimals="-5" id="ixv-7818" unitRef="usd">327000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c4" decimals="-5" id="ixv-7819" unitRef="usd">118300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c0" id="ixv-7820">P29Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="c3" decimals="-5" id="ixv-7821" unitRef="usd">8600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <mtx:FiniteLivedIntangibleAssetExpectedAmortizationYearsOneThroughFour contextRef="c3" decimals="-5" id="ixv-7822" unitRef="usd">46000000</mtx:FiniteLivedIntangibleAssetExpectedAmortizationYearsOneThroughFour>
    <mtx:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour contextRef="c3" decimals="-5" id="ixv-7823" unitRef="usd">150900000</mtx:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c0" id="ixv-3795">&lt;div&gt;&lt;span style="font-weight: bold;"&gt;Note 8.&#160;&#160;Derivative Financial Instruments&lt;/span&gt;
  &lt;/div&gt;&lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;As a multinational corporation with operations throughout the world, the Company is exposed to certain market risks. The Company uses a variety of practices to manage these market risks, including, when considered appropriate, derivative financial instruments. The Company&#x2019;s objective is to offset gains and losses resulting from interest rate and foreign currency exposures with gains and losses on the derivative contracts used to hedge them. The Company uses derivative financial instruments only for risk management and not for trading or speculative purposes.&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;By using derivative financial instruments to hedge exposures to changes in interest rates and foreign currencies, the Company exposes itself to credit risk and market risk. Credit risk is the risk that the counterparty will fail to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes the Company, which creates credit risk for the Company. When the fair value of a derivative contract is negative, the Company owes the counterparty, and therefore, it does not face any credit risk. The Company minimizes the credit risk in derivative instruments by entering into transactions with major financial institutions.&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;Market risk is the adverse effect on the value of a financial instrument that results from a change in interest rates, currency exchange rates, or commodity prices. The market risk associated with interest rate and forward exchange contracts is managed by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken.&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;

  &lt;div style="text-align: justify;"&gt;&lt;span style="font-style: italic;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Cash Flow Hedges&lt;/span&gt;
  &lt;/div&gt;&lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;For derivative instruments that are designated and qualify as cash flow hedges, the Company records the effective portion of the gain or loss in accumulated other comprehensive income (loss) as a separate component of shareholders&#x2019; equity.  The Company subsequently reclassifies the effective portion of gain or loss into earnings in the period during which the hedged transaction is recognized in earnings.&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The Company utilizes interest rate swaps to limit exposure to market fluctuations on floating-rate debt. In the second quarter of 2023, the Company entered into a floating to fixed interest rate swap for a notional amount of $150 million. The fair value of this swap is a liability less than $0.1 million at April 5, 2026 and is recorded in other current liabilities on the Condensed Consolidated Balance Sheet. This interest rate swap is designated as a cash flow hedge. As a result, the gains and losses associated with this interest rate swap are recorded in accumulated other comprehensive income (loss).&lt;/span&gt; &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;Assets and liabilities measured at fair value are based on one or more of three valuation techniques. The three valuation techniques are as follows:&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;ul style="list-style-type : disc; padding : 0px; margin : 0px 0px 0px -8px; "&gt;
    &lt;li style="text-align: justify; margin-left: 54pt; font-family: Calibri;"&gt;
     &lt;span style="font-family: Times New Roman; font-size: 10.0pt;"&gt;Market approach - prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.&lt;/span&gt;
    &lt;/li&gt;
    &lt;li style="text-align: justify; margin-left: 54pt; font-family: Calibri;"&gt;
     &lt;span style="font-family: Times New Roman; font-size: 10.0pt;"&gt;Cost approach - amount that would be required to replace the service capacity of an asset or replacement cost.&lt;/span&gt;
    &lt;/li&gt;
    &lt;li style="text-align: justify; margin-left: 54pt; font-family: Calibri;"&gt;
     &lt;span style="font-family: Times New Roman; font-size: 10.0pt;"&gt;Income approach - techniques to convert future amounts to a single present amount based on market expectations, including present value techniques, option-pricing and other models.&lt;/span&gt;
    &lt;/li&gt;
  &lt;/ul&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;The Company primarily applies the income approach for interest rate derivatives for recurring fair value measurements and attempts to utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;The fair value of our interest rate swap contract is determined based on inputs that are readily available in public markets or can be derived from information available in publicly quoted markets and is categorized as Level 2.&lt;/span&gt;
  &lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c74" decimals="-6" id="ixv-7824" unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue contextRef="c75" decimals="-5" id="ixv-7825" unitRef="usd">100000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:DebtDisclosureTextBlock contextRef="c0" id="ixv-3851">&lt;div&gt;&lt;span style="font-weight: bold;"&gt;Note 9.&#160;&#160;Long-Term Debt and Commitments&lt;/span&gt;
  &lt;/div&gt;&lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The following is a summary of long-term debt:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="LT DEBT - C2"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="LT DEBT - C2"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="LT DEBT - E2"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Dec. 31,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="LT DEBT - E2"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="LT DEBT - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="LT DEBT - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="LT DEBT - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="LT DEBT - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; font-style: italic;"&gt;Secured Credit Agreement:&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C4"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E4"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="text-indent: -10px; padding-left: 20px;"&gt;Term Loan due &lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;2031&lt;/span&gt;, net of unamortized deferred financing cost and original issue discount of $6.3 million and $6.5 million&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;" title="LT DEBT - C5"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;561.5&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;" title="LT DEBT - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;" title="LT DEBT - E5"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;562.7&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="LT DEBT - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C6"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C6"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E6"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E6"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; font-style: italic;"&gt;Senior Notes:&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C7"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C7"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E7"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E7"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-indent: -10px; padding-left: 20px;"&gt;5.00% due &lt;span style="-sec-ix-hidden: hidden-fact-3"&gt;2028&lt;/span&gt;, net of unamortized deferred financing costs of $2.1 million and $2.3 million&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="LT DEBT - C8"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;397.9&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="LT DEBT - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="LT DEBT - E8"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;397.7&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="LT DEBT - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Other debt&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-top: none; border-left: none; border-right: none; border-bottom: 1px solid black;" title="LT DEBT - C9"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none; vertical-align: bottom;"&gt;0.8&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - E9"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none; vertical-align: bottom;"&gt;0.9&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding-left: 10px;"&gt;          Total &lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: initial; border-style: none; border-color: initial; vertical-align: bottom;" title="LT DEBT - C10"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-width: initial; border-style: none; border-color: initial; vertical-align: bottom;"&gt;960.2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: initial; border-style: none; border-color: initial;" title="LT DEBT - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: initial; border-style: none; border-color: initial; vertical-align: bottom;" title="LT DEBT - E10"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-width: initial; border-style: none; border-color: initial; vertical-align: bottom;"&gt;961.3&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: initial; border-style: none; border-color: initial;" title="LT DEBT - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Less: Current maturities of long-term debt&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - C11"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none; vertical-align: bottom;"&gt;6.2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - E11"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none; vertical-align: bottom;"&gt;6.3&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-bottom: 1px solid black; border-left: none; border-right: none; border-top: none;" title="LT DEBT - E11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;Total long-term debt&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="LT DEBT - C12"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;"&gt;954.0&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="LT DEBT - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="LT DEBT - E12"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;"&gt;955.0&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="LT DEBT - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&#160;&lt;/div&gt;

  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span style="letter-spacing: normal; text-indent: 48px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"&gt;On November 26, 2024 the Company entered into a Refinancing Facility Agreement and Incremental Facility Amendment (the &#x201c;Amendment&#x201d;) to amend the Company&#x2019;s previous credit agreement (the &#x201c;Previous Credit Agreement; the previous credit agreement, as amended by the Amendment, being the &#x201c;Amended Credit Agreement&#x201d;).&#160;&lt;/span&gt;&lt;/div&gt;

  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size: 10pt;"&gt;The Amendment provides for, among other
things, a new senior secured revolving credit facility with aggregate
commitments of $400 million (the &#x201c;Revolving Facility&#x201d;), a portion of which may
be used for the issuance of letters of credit and swingline loans, and a new
senior secured term loan facility with aggregate commitments of $575 million
(the &#x201c;Term Loan Facility&#x201d; and, together with the Revolving Facility, the
"Senior Secured Credit Facilities"). The Revolving Facility and the
Term Loan Facility replace the facilities under the Previous Credit Agreement,
which provided for, among other things, a $550 million senior secured term loan
facility and a $300 million senior secured revolving credit facility. The
maturity date for loans and commitments under the Revolving Facility is
November 26, 2029, and the maturity date for loans under the Term Loan Facility
is November 26, 2031; provided that the maturity dates of the Revolving
Facility and the Term Loan Facility will be adjusted to the date that is 91 days
prior to the stated maturity date of the Company&#x2019;s 5.0%&#160;&#160;Senior Notes
due 2028 (the &#x201c;Notes&#x201d;) unless, prior to the date that is 91 days prior to the
stated maturity date of the Notes, all amounts in excess of $50 million of the
Notes have been either (a) refinanced with indebtedness permitted under the
Amended Credit Agreement maturing later than 90 days after the scheduled
maturity date of the Revolving Facility or of the Term Loan Facility, as
applicable, or (b) repaid, discharged or repaid (other than with the proceeds
of any indebtedness maturing earlier than 91 days after the scheduled maturity
date of the Revolving Facility or of the Term Loan Facility, as applicable).
Loans under the Term Loan Facility amortize at a rate equal to 1.00% per annum,
payable in equal quarterly installments, and were issued with original issue
discount at 99.875% of par.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;
  &#160;&lt;/div&gt;

  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size: 10pt;"&gt;Loans under the Revolving Facility will
bear interest at a rate equal to (a) for loans denominated in U.S. dollars, at
the election of the Company, Term SOFR plus an applicable margin equal to
1.375% per annum or a base rate plus an applicable margin equal to 0.375% per
annum, (b) for loans denominated in Euros, adjusted EURIBOR plus an applicable
margin equal to 1.375% per annum and (c) for loans denominated in Pounds
Sterling, SONIA plus an applicable margin equal to 1.375% per annum, subject in
each case to (i) an increase of 37.5 basis points in the event that, and for so
long as, the Net Leverage Ratio (as defined in the Amended Credit Agreement) is
greater than or equal to 3.00 to 1.00 as of the last day of the preceding
fiscal quarter, (ii) an increase of 12.5 basis points in the event that, and
for so long as, the Net Leverage Ratio is less than 3.00 to 1.00 and greater
than or equal to 2.00 to 1.00 as of the last day of the preceding fiscal
quarter, and (iii) a decrease of 12.5 basis points in the event that, and for
so long as, the Net Leverage Ratio is less than 1.00 to 1.00 as of the last day
of the preceding fiscal quarter. Loans under the Term Loan Facility will bear
interest at a rate equal to, at the election of the Company, Term SOFR plus an
applicable margin equal to 2.00% per annum or a base rate plus an applicable
margin equal to 1.00% per annum. The Company will pay certain fees under the
Amended Credit Agreement, including (a) a commitment fee of 0.175% per annum on
the undrawn portion of the Revolving Facility (subject to a step-ups to 0.300%
and 0.250% and a step-down to 0.150% at the same levels described above), (b) a
fronting fee of 0.125% per annum on the average daily undrawn amount of, plus
unreimbursed amounts in respect of disbursements under, letters of credit
issued under the Revolving Facility, and (c) customary annual administration
fees. The obligations of the Company under the Senior Secured Credit Facilities
are unconditionally guaranteed jointly and severally by, subject to certain
exceptions, all material domestic subsidiaries of the Company (the
&#x201c;Guarantors&#x201d;) and secured, subject to certain exceptions, by a security
interest in substantially all of the tangible and intangible assets of the
Company and the Guarantors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;As of April 5, 2026, there were $6.0 million in loans and $9.2 million in letters of credit outstanding under the Revolving Facility.&lt;/span&gt; &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;

  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;On June 30, 2020, the Company issued $400 million
aggregate principal amount of &#x201c;Notes.&#x201d;&#160;The Notes
were issued pursuant to an indenture, dated as of June 30, 2020, between the
Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the
&#x201c;Indenture&#x201d;). The Notes bear an interest rate of 5.0% per annum payable
semi-annually on January 1 and July 1 of each year, beginning on January 1,
2021. The Notes are unconditionally guaranteed on a senior unsecured basis by
each of the Company&#x2019;s existing and future wholly owned domestic restricted
subsidiaries that is a borrower under or that guarantees the Company&#x2019;s
obligations under its Senior Secured Credit Facilities or that guarantees the
Company&#x2019;s or any of the Company&#x2019;s wholly owned domestic subsidiaries&#x2019; long-term
indebtedness in an aggregate amount in excess of $50 million.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;
  &#160;&lt;/div&gt;

  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size: 10pt;"&gt;The Company may redeem some or all of the
Notes at any time and from time to time at the applicable redemption prices
listed in the Indenture, plus accrued and unpaid interest, if any, to, but
excluding, the applicable redemption date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin: 0in; font-size: 12pt; text-align: justify;"&gt;&lt;span style="font-size:10.0pt"&gt;&#160;
&lt;/span&gt;&lt;/div&gt;
  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size: 10pt;"&gt;If the Company experiences a change of
control (as defined in the indenture), the Company is required to offer to
repurchase the Notes at 101% of the principal amount of such Notes, plus
accrued and unpaid interest, if any, to, but excluding, the date of repurchase.&lt;/span&gt;&lt;/div&gt;




  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;The Amended Credit Agreement and the Indenture both
contain certain customary affirmative and negative covenants that limit or
restrict the ability of the Company and its restricted subsidiaries to enter
into certain transactions or take certain actions, as well as customary events
of default. In addition, the Amended Credit Agreement contains a financial
covenant that requires the Company to maintain a maximum Net Leverage Ratio of
4.00 to 1.00 for each four fiscal quarter period (subject to an increase to
5.00 to 1.00 for four quarters in connection with certain significant
acquisitions).&#160;The Company is in compliance with all the covenants
contained in the Amended Credit Agreement throughout the period covered by this
report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin: 0in; font-size: 12pt;"&gt;&lt;span style="font-size:10.0pt"&gt;&#160; &lt;/span&gt;&lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The Company has a committed loan facility in Japan. As of April 5, 2026, $0.3 million was outstanding under this loan facility. Principal will be repaid in accordance with the payment schedule ending in 2026. The Company repaid $0.1&#160;million on this loan during the first three months of 2026.&lt;/span&gt; &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;As part of the acquisition of Concept Pet Heimtierprodukte GmbH (&#x201c;Concept Pet&#x201d;) in 2022, the Company assumed $1.9 million in long-term debt, recorded at fair value, consisting of two terms loans, one that matured in 2025 and one that matures in 2027.&#160;The outstanding loan has annual payments and carries a variable interest rate. The Company did not make any repayments&#160;on this loan during the first three months of 2026.&lt;/span&gt; &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;As of April 5, 2026, the Company had $18.3 million in uncommitted short-term bank credit lines, of which none&#160;were in use.&lt;/span&gt; &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c0" id="ixv-3855">&lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The following is a summary of long-term debt:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="LT DEBT - C2"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="LT DEBT - C2"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="LT DEBT - E2"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Dec. 31,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="LT DEBT - E2"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="LT DEBT - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="LT DEBT - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="LT DEBT - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="LT DEBT - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; font-style: italic;"&gt;Secured Credit Agreement:&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C4"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E4"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="text-indent: -10px; padding-left: 20px;"&gt;Term Loan due &lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;2031&lt;/span&gt;, net of unamortized deferred financing cost and original issue discount of $6.3 million and $6.5 million&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;" title="LT DEBT - C5"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;561.5&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;" title="LT DEBT - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;" title="LT DEBT - E5"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;562.7&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="LT DEBT - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C6"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C6"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E6"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E6"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; font-style: italic;"&gt;Senior Notes:&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C7"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - C7"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E7"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="LT DEBT - E7"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-indent: -10px; padding-left: 20px;"&gt;5.00% due &lt;span style="-sec-ix-hidden: hidden-fact-3"&gt;2028&lt;/span&gt;, net of unamortized deferred financing costs of $2.1 million and $2.3 million&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="LT DEBT - C8"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;397.9&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="LT DEBT - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="LT DEBT - E8"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;397.7&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="LT DEBT - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Other debt&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-top: none; border-left: none; border-right: none; border-bottom: 1px solid black;" title="LT DEBT - C9"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none; vertical-align: bottom;"&gt;0.8&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - E9"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none; vertical-align: bottom;"&gt;0.9&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding-left: 10px;"&gt;          Total &lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: initial; border-style: none; border-color: initial; vertical-align: bottom;" title="LT DEBT - C10"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-width: initial; border-style: none; border-color: initial; vertical-align: bottom;"&gt;960.2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: initial; border-style: none; border-color: initial;" title="LT DEBT - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: initial; border-style: none; border-color: initial; vertical-align: bottom;" title="LT DEBT - E10"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-width: initial; border-style: none; border-color: initial; vertical-align: bottom;"&gt;961.3&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: initial; border-style: none; border-color: initial;" title="LT DEBT - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Less: Current maturities of long-term debt&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - C11"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none; vertical-align: bottom;"&gt;6.2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="LT DEBT - E11"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none; vertical-align: bottom;"&gt;6.3&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-bottom: 1px solid black; border-left: none; border-right: none; border-top: none;" title="LT DEBT - E11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;Total long-term debt&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="LT DEBT - C12"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;"&gt;954.0&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="LT DEBT - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;" title="LT DEBT - E12"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none; vertical-align: bottom;"&gt;955.0&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="LT DEBT - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DeferredFinanceCostsNet contextRef="c106" decimals="-5" id="ixv-7826" unitRef="usd">6300000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="c107" decimals="-5" id="ixv-7827" unitRef="usd">6500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt contextRef="c106" decimals="-5" id="ixv-7828" unitRef="usd">561500000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c107" decimals="-5" id="ixv-7829" unitRef="usd">562700000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c83"
      decimals="INF"
      id="ixv-7830"
      unitRef="pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c108"
      decimals="INF"
      id="ixv-7831"
      unitRef="pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DeferredFinanceCostsNet contextRef="c83" decimals="-5" id="ixv-7832" unitRef="usd">2100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="c108" decimals="-5" id="ixv-7833" unitRef="usd">2300000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt contextRef="c83" decimals="-5" id="ixv-7834" unitRef="usd">397900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c108" decimals="-5" id="ixv-7835" unitRef="usd">397700000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c110" decimals="-5" id="ixv-7836" unitRef="usd">800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c111" decimals="-5" id="ixv-7837" unitRef="usd">900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c3" decimals="-5" id="ixv-7838" unitRef="usd">960200000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c4" decimals="-5" id="ixv-7839" unitRef="usd">961300000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="c3" decimals="-5" id="ixv-7840" unitRef="usd">6200000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c4" decimals="-5" id="ixv-7841" unitRef="usd">6300000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c3" decimals="-5" id="ixv-7842" unitRef="usd">954000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c4" decimals="-5" id="ixv-7843" unitRef="usd">955000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c76" decimals="-6" id="ixv-7844" unitRef="usd">400000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c77" decimals="-6" id="ixv-7845" unitRef="usd">575000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c78" decimals="-6" id="ixv-7846" unitRef="usd">550000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c79" decimals="-6" id="ixv-7847" unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentMaturityDate contextRef="c80" id="ixv-7848">2029-11-26</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="c81" id="ixv-7849">2031-11-26</us-gaap:DebtInstrumentMaturityDate>
    <mtx:DebtInstrumentPeriodPriorToStatedMaturityDateOfSeniorNotes contextRef="c82" id="ixv-7850">P91D</mtx:DebtInstrumentPeriodPriorToStatedMaturityDateOfSeniorNotes>
    <mtx:DebtInstrumentPeriodPriorToStatedMaturityDateOfSeniorNotes contextRef="c82" id="ixv-7851">P91D</mtx:DebtInstrumentPeriodPriorToStatedMaturityDateOfSeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c83"
      decimals="INF"
      id="ixv-7852"
      unitRef="pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <mtx:DebtInstrumentPeriodPriorToStatedMaturityDateOfSeniorNotes contextRef="c82" id="ixv-7853">P91D</mtx:DebtInstrumentPeriodPriorToStatedMaturityDateOfSeniorNotes>
    <mtx:DebtInstrumentThresholdAmountOfSeniorNotes contextRef="c84" decimals="-6" id="ixv-7854" unitRef="usd">50000000</mtx:DebtInstrumentThresholdAmountOfSeniorNotes>
    <mtx:DebtInstrumentTermAfterScheduledMaturityDateOfFacility contextRef="c82" id="ixv-7855">P90D</mtx:DebtInstrumentTermAfterScheduledMaturityDateOfFacility>
    <mtx:DebtInstrumentPeriodPriorToStatedMaturityDateOfSeniorNotes contextRef="c82" id="ixv-7856">P91D</mtx:DebtInstrumentPeriodPriorToStatedMaturityDateOfSeniorNotes>
    <mtx:DebtInstrumentAmortizationRateOfLoans
      contextRef="c81"
      decimals="INF"
      id="ixv-7857"
      unitRef="pure">0.01</mtx:DebtInstrumentAmortizationRateOfLoans>
    <mtx:OriginalIssueDiscountRate
      contextRef="c81"
      decimals="INF"
      id="ixv-7858"
      unitRef="pure">0.99875</mtx:OriginalIssueDiscountRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c85"
      decimals="INF"
      id="ixv-7859"
      unitRef="pure">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c86"
      decimals="INF"
      id="ixv-7860"
      unitRef="pure">0.00375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c87"
      decimals="INF"
      id="ixv-7861"
      unitRef="pure">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c88"
      decimals="INF"
      id="ixv-7862"
      unitRef="pure">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <mtx:AdjustmentToApplicableMarginCategory1
      contextRef="c80"
      decimals="INF"
      id="ixv-7863"
      unitRef="pure">0.00375</mtx:AdjustmentToApplicableMarginCategory1>
    <mtx:DebtInstrumentNetLeverageRatioCategory1
      contextRef="c89"
      decimals="INF"
      id="ixv-7864"
      unitRef="pure">3</mtx:DebtInstrumentNetLeverageRatioCategory1>
    <mtx:AdjustmentToApplicableMarginCategory2
      contextRef="c80"
      decimals="INF"
      id="ixv-7865"
      unitRef="pure">0.00125</mtx:AdjustmentToApplicableMarginCategory2>
    <mtx:DebtInstrumentNetLeverageRatioCategory2
      contextRef="c90"
      decimals="INF"
      id="ixv-7866"
      unitRef="pure">3</mtx:DebtInstrumentNetLeverageRatioCategory2>
    <mtx:DebtInstrumentNetLeverageRatioCategory2
      contextRef="c89"
      decimals="INF"
      id="ixv-7867"
      unitRef="pure">2</mtx:DebtInstrumentNetLeverageRatioCategory2>
    <mtx:AdjustmentToApplicableMarginCategory3
      contextRef="c80"
      decimals="INF"
      id="ixv-7868"
      unitRef="pure">-0.00125</mtx:AdjustmentToApplicableMarginCategory3>
    <mtx:DebtInstrumentNetLeverageRatioCategory3
      contextRef="c90"
      decimals="INF"
      id="ixv-7869"
      unitRef="pure">1</mtx:DebtInstrumentNetLeverageRatioCategory3>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c91"
      decimals="INF"
      id="ixv-7870"
      unitRef="pure">0.02</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c92"
      decimals="INF"
      id="ixv-7871"
      unitRef="pure">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c80"
      decimals="INF"
      id="ixv-7872"
      unitRef="pure">0.00175</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <mtx:DebtInstrumentStepUpCommitmentFee
      contextRef="c90"
      decimals="INF"
      id="ixv-7873"
      unitRef="pure">0.003</mtx:DebtInstrumentStepUpCommitmentFee>
    <mtx:DebtInstrumentStepUpCommitmentFee
      contextRef="c89"
      decimals="INF"
      id="ixv-7874"
      unitRef="pure">0.0025</mtx:DebtInstrumentStepUpCommitmentFee>
    <mtx:DebtInstrumentStepDownCommitmentFee
      contextRef="c80"
      decimals="INF"
      id="ixv-7875"
      unitRef="pure">0.0015</mtx:DebtInstrumentStepDownCommitmentFee>
    <mtx:DebtInstrumentFrontingFee
      contextRef="c80"
      decimals="INF"
      id="ixv-7876"
      unitRef="pure">0.00125</mtx:DebtInstrumentFrontingFee>
    <us-gaap:LongTermDebt contextRef="c93" decimals="-5" id="ixv-7877" unitRef="usd">6000000</us-gaap:LongTermDebt>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="c93" decimals="-5" id="ixv-7878" unitRef="usd">9200000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c94" decimals="-6" id="ixv-7879" unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c83"
      decimals="INF"
      id="ixv-7880"
      unitRef="pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <mtx:DebtInstrumentGuaranteeAmount contextRef="c83" decimals="-6" id="ixv-7881" unitRef="usd">50000000</mtx:DebtInstrumentGuaranteeAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c95"
      decimals="INF"
      id="ixv-7882"
      unitRef="pure">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <mtx:DebtInstrumentNetLeverageRatio
      contextRef="c96"
      decimals="INF"
      id="ixv-7883"
      unitRef="pure">4</mtx:DebtInstrumentNetLeverageRatio>
    <mtx:DebtInstrumentFinancialCovenantNumberOfQuartersToMaintainNetLeverageRatio
      contextRef="c97"
      decimals="INF"
      id="ixv-7884"
      unitRef="Quarter">4</mtx:DebtInstrumentFinancialCovenantNumberOfQuartersToMaintainNetLeverageRatio>
    <mtx:DebtInstrumentNetLeverageRatioInConnectionWithCertainSignificantAcquisitions
      contextRef="c96"
      decimals="INF"
      id="ixv-7885"
      unitRef="pure">5</mtx:DebtInstrumentNetLeverageRatioInConnectionWithCertainSignificantAcquisitions>
    <mtx:DebtInstrumentFinancialCovenantNumberOfQuartersToMaintainNetLeverageRatio
      contextRef="c97"
      decimals="INF"
      id="ixv-7886"
      unitRef="Quarter">4</mtx:DebtInstrumentFinancialCovenantNumberOfQuartersToMaintainNetLeverageRatio>
    <us-gaap:LongTermDebt contextRef="c98" decimals="-5" id="ixv-7887" unitRef="usd">300000</us-gaap:LongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c99" decimals="-5" id="ixv-7888" unitRef="usd">100000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c100" decimals="-5" id="ixv-7889" unitRef="usd">1900000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <mtx:NumberOfTermLoans
      contextRef="c101"
      decimals="INF"
      id="ixv-7890"
      unitRef="Loan">2</mtx:NumberOfTermLoans>
    <mtx:NumberOfTermLoansThatMature
      contextRef="c102"
      decimals="INF"
      id="ixv-7891"
      unitRef="Loan">1</mtx:NumberOfTermLoansThatMature>
    <mtx:NumberOfTermLoansThatMature
      contextRef="c103"
      decimals="INF"
      id="ixv-7892"
      unitRef="Loan">1</mtx:NumberOfTermLoansThatMature>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c104" decimals="-6" id="ixv-7893" unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c105" decimals="-5" id="ixv-7894" unitRef="usd">18300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ShortTermBorrowings contextRef="c105" decimals="-6" id="ixv-7895" unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c0" id="ixv-4025">&lt;div style="text-indent: -45.1pt; text-align: justify; padding-left: 45.1pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 10.&#160;&#160;Benefit Plans&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The Company and its subsidiaries have pension plans covering the majority of its eligible employees on a contributory or non-contributory basis. The Company also provides postretirement health care and life insurance benefits for the majority of its U.S. retired employees. Disclosures for the U.S. plans have been combined with those outside of the U.S., as the international plans do not have significantly different assumptions, and together represent less than 20% of our total benefit obligation.&lt;/span&gt; &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div&gt; &lt;span style="font-weight: bold;"&gt;Components of Net Periodic Benefit Cost &lt;/span&gt; &lt;/div&gt;





  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align : center; font-weight : bold; border-color : black; white-space : nowrap; "&gt;Pension Benefits&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 1px; border-style: none none solid;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td style="font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - C5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - E5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Service cost &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Interest cost &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;4.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;4.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Expected return on plan assets &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(5.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C8"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(5.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E8"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Amortization:&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - C9"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - C9"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - E9"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - E9"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;     Recognized net actuarial loss &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="BENEFITS - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="BENEFITS - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="BENEFITS - E10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;0.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="BENEFITS - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; padding-left: 20px;"&gt;          Net periodic benefit cost &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="BENEFITS - C12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(0.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="BENEFITS - C12"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="BENEFITS - E12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="BENEFITS - E12"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align : center; font-weight : bold; border-color : black; white-space : nowrap; "&gt;Postretirement Benefits&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 1px; border-style: none none solid;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td style="font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td colspan="1" style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="BENEFITS - C16"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="BENEFITS - C16"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - C18"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - C18"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - E18"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - E18"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Service cost &lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C19"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;-&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C19"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E19"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;-&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E19"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Interest cost &lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C20"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;-&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C20"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E20"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;-&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E20"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Amortization:&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C22"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C22"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E22"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E22"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;     Recognized net actuarial gain&lt;/td&gt;&lt;td style="text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%;" title="BENEFITS - C23"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;(0.1&lt;/td&gt;&lt;td style="text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%;" title="BENEFITS - C23"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%;" title="BENEFITS - E23"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;(0.1&lt;/td&gt;&lt;td style="text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%;" title="BENEFITS - E23"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 20px;"&gt;          Net periodic benefit cost &lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="BENEFITS - C24"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;(0.1&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="BENEFITS - C24"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="BENEFITS - E24"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;(0.1&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="BENEFITS - E24"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&#160;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;Amortization amounts of prior service costs and recognized net actuarial losses are recorded, net of tax, as increases to accumulated other comprehensive income.&lt;/span&gt;
  &lt;/div&gt;


  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span&gt;The Company expects to contribute approximately $10.8 million to its pension plans and $0.1 million to its other postretirement benefit plans in 2026. As of April 5, 2026, $1.9 million has been contributed to the pension plans and no contributions have been made to the other postretirement benefit plans.&lt;/span&gt; &lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <mtx:PercentageOfTotalBenefitObligationForInternationalPensionPlans contextRef="c3" decimals="2" id="ixv-7896" unitRef="pure">0.20</mtx:PercentageOfTotalBenefitObligationForInternationalPensionPlans>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock contextRef="c0" id="ixv-4032">&lt;div&gt; &lt;span style="font-weight: bold;"&gt;Components of Net Periodic Benefit Cost &lt;/span&gt; &lt;/div&gt;





  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align : center; font-weight : bold; border-color : black; white-space : nowrap; "&gt;Pension Benefits&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 1px; border-style: none none solid;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td style="font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - C5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - E5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Service cost &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Interest cost &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;4.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;4.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Expected return on plan assets &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(5.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - C8"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(5.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="BENEFITS - E8"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Amortization:&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - C9"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - C9"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - E9"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="BENEFITS - E9"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;     Recognized net actuarial loss &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="BENEFITS - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="BENEFITS - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="BENEFITS - E10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;0.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="BENEFITS - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; padding-left: 20px;"&gt;          Net periodic benefit cost &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="BENEFITS - C12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(0.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="BENEFITS - C12"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="BENEFITS - E12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="BENEFITS - E12"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align : center; font-weight : bold; border-color : black; white-space : nowrap; "&gt;Postretirement Benefits&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 1px; border-style: none none solid;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td style="font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td colspan="1" style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="BENEFITS - C16"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 1%;" title="BENEFITS - C16"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - C18"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - C18"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - E18"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="BENEFITS - E18"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Service cost &lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C19"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;-&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C19"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E19"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;-&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E19"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Interest cost &lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C20"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;-&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C20"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E20"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;-&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E20"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Amortization:&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C22"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - C22"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E22"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="BENEFITS - E22"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;     Recognized net actuarial gain&lt;/td&gt;&lt;td style="text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%;" title="BENEFITS - C23"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;(0.1&lt;/td&gt;&lt;td style="text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%;" title="BENEFITS - C23"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%;" title="BENEFITS - E23"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 9%;"&gt;(0.1&lt;/td&gt;&lt;td style="text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; width: 1%;" title="BENEFITS - E23"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 20px;"&gt;          Net periodic benefit cost &lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="BENEFITS - C24"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;(0.1&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="BENEFITS - C24"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="BENEFITS - E24"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;(0.1&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="BENEFITS - E24"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c114" decimals="-5" id="ixv-7897" unitRef="usd">900000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c116" decimals="-5" id="ixv-7898" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c114" decimals="-5" id="ixv-7899" unitRef="usd">4000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c116" decimals="-5" id="ixv-7900" unitRef="usd">4200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c114" decimals="-5" id="ixv-7901" unitRef="usd">5900000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c116" decimals="-5" id="ixv-7902" unitRef="usd">5500000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c114" decimals="-5" id="ixv-7903" unitRef="usd">-100000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c116" decimals="-5" id="ixv-7904" unitRef="usd">-200000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c114" decimals="-5" id="ixv-7905" unitRef="usd">-900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c116" decimals="-5" id="ixv-7906" unitRef="usd">-100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c117" decimals="-6" id="ixv-7907" unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c118" decimals="-6" id="ixv-7908" unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c117" decimals="-6" id="ixv-7909" unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c118" decimals="-6" id="ixv-7910" unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c117" decimals="-5" id="ixv-7911" unitRef="usd">100000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c118" decimals="-5" id="ixv-7912" unitRef="usd">100000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c117" decimals="-5" id="ixv-7913" unitRef="usd">-100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c118" decimals="-5" id="ixv-7914" unitRef="usd">-100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear contextRef="c112" decimals="-5" id="ixv-7915" unitRef="usd">10800000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear contextRef="c113" decimals="-5" id="ixv-7916" unitRef="usd">100000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c114" decimals="-5" id="ixv-7917" unitRef="usd">1900000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c115" decimals="-6" id="ixv-7918" unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="c0" id="ixv-4229">&lt;div style="text-indent: -45.1pt; padding-left: 45.1pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 11.&#160;&#160;Comprehensive Income&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The following table summarizes the amounts reclassified out of accumulated other comprehensive loss attributable to the Company:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="OCI - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Apr. 5,&lt;/td&gt;&lt;td title="OCI - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="OCI - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Mar. 30,&lt;/td&gt;&lt;td title="OCI - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="OCI - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="OCI - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="OCI - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="OCI - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Amortization of pension items:&lt;/td&gt;&lt;td title="OCI - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="OCI - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="OCI - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="OCI - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;Pre-tax amount&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding-left: 10px;"&gt;Tax&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;Net of tax&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI - C8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI - E8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&#160;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;The pre-tax amounts in the table above are included within the components of net periodic pension benefit cost (see Note 10 to the Condensed Consolidated Financial Statements) and the tax amounts are included within the provision (benefit) for taxes on income line within the Condensed Consolidated Statements of Income (Loss).&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt;"&gt; &lt;span&gt;The major components of accumulated other comprehensive loss, net of related tax, attributable to MTI are as follows:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; white-space: nowrap; vertical-align: bottom; width: 9%;"&gt;Foreign Currency&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; white-space: nowrap; vertical-align: bottom; width: 9%;"&gt;Net Gain (Loss)&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I3"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom; width: 9%;"&gt;Translation&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom; width: 9%;"&gt;Unrecognized&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom; width: 9%;"&gt;on Derivative&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I4"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom; width: 9%;"&gt;Adjustment&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; white-space: nowrap; vertical-align: bottom; width: 9%;"&gt;Pension Costs&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom; width: 9%;"&gt;Instruments&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom; width: 9%;"&gt;Total&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Balance as of December 31, 2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(360.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;10.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;10.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(340.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I6"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="white-space: nowrap; text-indent: -10px; padding-left: 20px;"&gt;Other comprehensive income (loss) before reclassifications &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(13.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(13.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I7"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;Amounts reclassified from AOCI&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: bottom; text-indent: -10px; padding-left: 10px;"&gt;Net current period other comprehensive income (loss) &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;"&gt;(13.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;)&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G9"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;"&gt;(13.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I9"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Balance as of April 5, 2026&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;(374.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;10.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;10.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;(353.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I10"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock contextRef="c0" id="ixv-4233">&lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The following table summarizes the amounts reclassified out of accumulated other comprehensive loss attributable to the Company:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="OCI - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Apr. 5,&lt;/td&gt;&lt;td title="OCI - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="OCI - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Mar. 30,&lt;/td&gt;&lt;td title="OCI - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="OCI - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="OCI - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="OCI - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="OCI - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Amortization of pension items:&lt;/td&gt;&lt;td title="OCI - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="OCI - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="OCI - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="OCI - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;Pre-tax amount&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding-left: 10px;"&gt;Tax&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;Net of tax&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI - C8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI - E8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c119" decimals="-6" id="ixv-7919" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax contextRef="c120" decimals="-5" id="ixv-7920" unitRef="usd">100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c119" decimals="-6" id="ixv-7921" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c120" decimals="-6" id="ixv-7922" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c119" decimals="-6" id="ixv-7923" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="c120" decimals="-5" id="ixv-7924" unitRef="usd">100000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c0" id="ixv-4308">&lt;div style="text-indent: 36pt;"&gt; &lt;span&gt;The major components of accumulated other comprehensive loss, net of related tax, attributable to MTI are as follows:&lt;/span&gt; &lt;/div&gt;



  &lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; white-space: nowrap; vertical-align: bottom; width: 9%;"&gt;Foreign Currency&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; white-space: nowrap; vertical-align: bottom; width: 9%;"&gt;Net Gain (Loss)&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I3"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom; width: 9%;"&gt;Translation&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom; width: 9%;"&gt;Unrecognized&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom; width: 9%;"&gt;on Derivative&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I4"&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom; width: 9%;"&gt;Adjustment&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; white-space: nowrap; vertical-align: bottom; width: 9%;"&gt;Pension Costs&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom; width: 9%;"&gt;Instruments&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom; width: 9%;"&gt;Total&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Balance as of December 31, 2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(360.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;10.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;10.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(340.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I6"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="white-space: nowrap; text-indent: -10px; padding-left: 20px;"&gt;Other comprehensive income (loss) before reclassifications &lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(13.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(13.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I7"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;Amounts reclassified from AOCI&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: bottom; text-indent: -10px; padding-left: 10px;"&gt;Net current period other comprehensive income (loss) &lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;"&gt;(13.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;)&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;"&gt;0.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G9"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;"&gt;(13.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; vertical-align: bottom;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I9"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Balance as of April 5, 2026&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;(374.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;10.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;10.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - G10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;(353.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="OCI Note - Minerals Technologies XBRL 10Q Q3 2025 - I10"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity contextRef="c121" decimals="-5" id="ixv-7925" unitRef="usd">-360900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c122" decimals="-5" id="ixv-7926" unitRef="usd">10300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c123" decimals="-5" id="ixv-7927" unitRef="usd">10200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="-5" id="ixv-7928" unitRef="usd">-340400000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c124" decimals="-5" id="ixv-7929" unitRef="usd">-13200000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c125" decimals="-6" id="ixv-7930" unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c126" decimals="-6" id="ixv-7931" unitRef="usd">0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent contextRef="c16" decimals="-5" id="ixv-7932" unitRef="usd">-13200000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c124" decimals="-6" id="ixv-7933" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c125" decimals="-6" id="ixv-7934" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c126" decimals="-5" id="ixv-7935" unitRef="usd">-100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c16" decimals="-5" id="ixv-7936" unitRef="usd">-100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c124" decimals="-5" id="ixv-7937" unitRef="usd">-13200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c125" decimals="-6" id="ixv-7938" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c126" decimals="-5" id="ixv-7939" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c16" decimals="-5" id="ixv-7940" unitRef="usd">-13100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c127" decimals="-5" id="ixv-7941" unitRef="usd">-374100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c128" decimals="-5" id="ixv-7942" unitRef="usd">10300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c129" decimals="-5" id="ixv-7943" unitRef="usd">10300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="-5" id="ixv-7944" unitRef="usd">-353500000</us-gaap:StockholdersEquity>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-4467">&lt;div style="text-indent: -45.1pt; padding-left: 45.1pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 12.&#160;&#160;Contingencies&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;

  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size: 10pt;"&gt;The Company is party to a number of
lawsuits arising in the normal course of our business. The Company and certain
of the Company&#x2019;s subsidiaries are among numerous defendants in a number of
cases seeking damages for alleged exposure to asbestos-contaminated talc
products sold by the Company&#x2019;s subsidiary BMI Oldco Inc (f/k/a Barretts Minerals Inc.) ("Oldco").&lt;/span&gt;&lt;/div&gt;&lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size: 10pt;"&gt;On October 2, 2023 (the &#x201c;Petition Date&#x201d;),
notwithstanding the Company&#x2019;s confidence in the safety of Oldco&#x2019;s talc
products, the Company&#x2019;s subsidiaries, Oldco and Barretts Ventures Texas LLC
("BVT" and, together with Oldco, the &#x201c;Chapter 11 Debtors&#x201d;), filed
voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in
the United States Bankruptcy Court for the Southern District of Texas (the
&#x201c;Chapter 11 Cases&#x201d;) to address and comprehensively resolve Oldco&#x2019;s liabilities
associated with talc. Minerals Technologies Inc. and the Company&#x2019;s other
subsidiaries were not included in the Chapter 11 filing.&lt;/span&gt;&lt;span style="font-size:10.0pt"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;

  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size: 10pt;"&gt;The Chapter 11 Debtors&#x2019; ultimate goal in
the Chapter 11 Cases is to confirm a plan of reorganization under Section
524(g) of the U.S. Bankruptcy Code and utilize this provision of the Bankruptcy
Code to establish a trust that will address all current and future talc-related
claims. Discussions regarding the terms of a potential consensual plan of
reorganization and the ultimate amount to be contributed to any trust are
ongoing.&lt;/span&gt;&lt;/div&gt;




  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span style="color: #000000;"&gt;As of April 5, 2026, we had 978&lt;/span&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;span style="color: #000000;"&gt;open cases related to certain talc products previously sold by Oldco, which is an increase in volume from previous years. The following table details case activity related to talc products previously sold by Oldco:&lt;/span&gt; &lt;/div&gt;&lt;div style="text-align: justify;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="CONTINGENCIES - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;" title="CONTINGENCIES - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="CONTINGENCIES - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="width: 1%;" title="CONTINGENCIES - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(number of claims)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="CONTINGENCIES - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="CONTINGENCIES - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="CONTINGENCIES - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="CONTINGENCIES - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="vertical-align: bottom;"&gt;Claims pending, beginning of period&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;914&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;684&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: bottom;"&gt;Claims filed&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;114&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;67&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="vertical-align: bottom;"&gt;Less:  Claims dismissed, settled, or otherwise resolved&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;50&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: bottom;"&gt;Claims pending, end of period&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;978&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;715&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align: justify;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;These claims typically allege various theories of
liability, including negligence, gross negligence, and strict liability and
seek compensatory and, in some cases, punitive damages, but most of these
claims do not provide adequate information to assess their merits, the
likelihood that the Company will be found liable, or the magnitude of such
liability, if any. We are unable to state an amount or range of amounts claimed
in any of these lawsuits because state court pleading practices do not require
the plaintiff to identify the amount of the claimed damage. The Company&#x2019;s
position, as stated publicly, is that the talc products sold by Oldco are safe
and do not cause cancer.&lt;/span&gt;&lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;

  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;During the pendency of the Chapter 11 Cases, the
Company anticipates that the Chapter 11 Debtors will benefit from the operation
of the automatic stay, which stays ongoing litigation in connection with
talc-related claims against the Chapter 11 Debtors. In addition, the Bankruptcy
Court temporarily enjoined the filing or continued prosecution of all
talc-related claims against the Chapter 11 Debtors&#x2019; non-debtor affiliates,
subject to certain exceptions. Such exceptions consist of claims premised
solely on alleged inadequacies in testing of talc sold by Oldco.&#160;The
Company is vigorously opposing and defending against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;


  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;While costs relating to the talc-related cases have
increased concurrently with the volume, the majority of these costs have
historically been borne by Pfizer Inc. (&#x201c;Pfizer&#x201d;) in connection with certain
agreements entered into in connection with the Company&#x2019;s initial public
offering in 1992, and as long as the litigation is subject to the stay under
the Chapter 11 Cases (subject to certain exceptions), the Company will not be
required to make substantial payments in respect thereof. The Company is entitled to indemnification,
pursuant to agreement, for liabilities arising from sales prior to the initial
public offering. On May 22, 2024, Pfizer filed a motion in the Chapter 11 Cases
seeking permission to file a lawsuit against the Company related to the 1992
agreement. That motion has been adjourned, and Pfizer and the Company have
agreed to mediate their disputes. The Company continues to receive information
from Pfizer with respect to potential costs associated with the defense and/or
settlement of talc-related cases that Pfizer alleges are not subject to
indemnification. Although the Company believes that the talc products are safe
and that claims to the contrary are without merit, the Company and Oldco have opportunistically
settled certain talc-related cases not settled by Pfizer. None of such settlements
were material to the Company. &lt;/span&gt;&lt;/div&gt;

  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;
  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;In the second quarter of 2024, Oldco sold its talc
assets under section 363 of the Bankruptcy Code. In addition, in the second
quarter of 2024, the Company entered into a Debtor-in-Possession Credit
Agreement with Oldco (the &#x201c;DIP Credit Agreement&#x201d;) and recorded a provision for
credit loss of&#160;$30 million for the maximum principal amount under such
Credit Agreement.&#160;In the second quarter of 2025, the Company agreed to
amend the DIP Credit Agreement to increase the maximum principal amount under such
Credit Agreement by $30 million.&#160;Proceeds of the sale of Oldco&#x2019;s talc
assets and funds drawn by Oldco under the DIP Credit Agreement have been and
will be used to fund the Chapter 11 Cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;Following the Chapter 11 filing, the activities of the
Chapter 11 Debtors are now subject to review and oversight by the bankruptcy
court. As a result, the Chapter 11 Debtors were deconsolidated as of the
Petition Date, and their assets and liabilities were derecognized from the
Company&#x2019;s consolidated financial statements on a prospective basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;

  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   On June 25, 2024, the committee representing
talc claimants (the &#x201c;Committee&#x201d;) filed a motion to dismiss the Chapter 11
Cases.&#160;The Bankruptcy Court denied that motion on April 29, 2025 and the
United States District Court for the Southern District of Texas (the &#x201c;District
Court&#x201d;) denied the Committee's motion seeking leave to appeal that order on March 23, 2026.
  &lt;/div&gt;&lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;

  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;On May 14, 2025, the Bankruptcy Court entered a
Report and Recommendation (i) recommending that the District Court determine
whether any of the talc sold by Oldco contained sufficient quantity and form of
asbestos to cause mesothelioma or other asbestos-related diseases and (ii)
abating the Chapter 11 Cases pending a determination by the District
Court.&#160;The Company supports this path forward.&#160;The Chapter 11 Cases
remain pending.
  &lt;/div&gt;&lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;

  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;In the first quarter of 2025, the Company recorded a
provision to establish an accrual of $215 million for estimated costs to fund a
trust to resolve all current and future talc-related claims as well as fund the
Chapter 11 Cases and related litigation costs (including the aforementioned $30
million increase to the maximum principal amount of the DIP Credit
Agreement).&#160;The parties have not yet reached a final resolution of all
matters in the Chapter 11 Cases, and the Company is unable to estimate the
possible loss or range of loss beyond the amount accrued.&lt;/span&gt;&lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;
  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;The Company records accruals for loss contingencies
associated with legal matters, including talc-related litigation and the
Chapter 11 Cases, when it is probable that a liability will be incurred and the
amount of the loss can be reasonably estimated. Amounts accrued for legal
contingencies often result from a complex series of judgments about future
events and uncertainties that rely heavily on estimates and assumptions
including timing of related payments. The ability to make such estimates and
judgments can be affected by various factors, including whether damages sought
in the proceedings are unsubstantiated or indeterminate, the stage of the
litigation, the factual and legal matters in dispute, the ability to achieve
comprehensive settlements, the availability of co-defendants with substantial
resources and assets participating in the litigation, and our evaluation of the
unique attributes of each claim.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;



  &lt;div style="margin: 0in; font-size: 12pt; text-align: justify; text-indent: 0.5in;"&gt;&lt;span style="font-size:10.0pt"&gt;The broader litigation and regulatory environments for
talc-related claims continue to evolve. Moreover, although the Chapter 11 Cases
are progressing, it is not possible at this time to predict how the District
Court will rule on the pending motions,  the form of any ultimate resolution or when an ultimate resolution
might occur.&#160;Given the foregoing factors, it is reasonably possible that the
Company will incur a loss for liabilities associated with talc claims in excess
of the amount accrued. This risk is based on the potential for new talc-related
claims that could eventually be asserted together with their associated
disposition cost and related legal costs, despite the automatic stay with
respect to claims against the Chapter 11 Debtors, taking into account the
portion of such hypothetical claims that may be subject to indemnification by
Pfizer, as well as the inability to predict the amount that may ultimately be
necessary to fully and finally resolve all of the Chapter 11 Debtors&#x2019; future
talc-related claims in connection with a confirmed Chapter 11 plan of
reorganization. In light of the uncertainties involved in such matters, the resolution
of, or recognition of additional liabilities in connection with, current or
future talc claims could have a material adverse effect on the Company&#x2019;s
results of operations, cash flows, and financial condition.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock contextRef="c0" id="ixv-4498">&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span style="color: #000000;"&gt;As of April 5, 2026, we had 978&lt;/span&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;span style="color: #000000;"&gt;open cases related to certain talc products previously sold by Oldco, which is an increase in volume from previous years. The following table details case activity related to talc products previously sold by Oldco:&lt;/span&gt; &lt;/div&gt;&lt;div style="text-align: justify;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="CONTINGENCIES - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;" title="CONTINGENCIES - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="CONTINGENCIES - E3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="width: 1%;" title="CONTINGENCIES - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(number of claims)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="CONTINGENCIES - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="CONTINGENCIES - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="CONTINGENCIES - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="CONTINGENCIES - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="vertical-align: bottom;"&gt;Claims pending, beginning of period&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;914&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;684&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: bottom;"&gt;Claims filed&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;114&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;67&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="CONTINGENCIES - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="vertical-align: bottom;"&gt;Less:  Claims dismissed, settled, or otherwise resolved&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;50&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: bottom;"&gt;Claims pending, end of period&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;978&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;715&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="CONTINGENCIES - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c130"
      decimals="INF"
      id="ixv-7945"
      unitRef="Claim">978</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c133"
      decimals="INF"
      id="ixv-7946"
      unitRef="Claim">914</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c134"
      decimals="INF"
      id="ixv-7947"
      unitRef="Claim">684</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="c135"
      decimals="INF"
      id="ixv-7948"
      unitRef="Claim">114</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="c136"
      decimals="INF"
      id="ixv-7949"
      unitRef="Claim">67</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyClaimsSettledAndDismissedNumber
      contextRef="c135"
      decimals="INF"
      id="ixv-7950"
      unitRef="Claim">50</us-gaap:LossContingencyClaimsSettledAndDismissedNumber>
    <us-gaap:LossContingencyClaimsSettledAndDismissedNumber
      contextRef="c136"
      decimals="INF"
      id="ixv-7951"
      unitRef="Claim">36</us-gaap:LossContingencyClaimsSettledAndDismissedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c130"
      decimals="INF"
      id="ixv-7952"
      unitRef="Claim">978</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c137"
      decimals="INF"
      id="ixv-7953"
      unitRef="Claim">715</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:DebtorReorganizationItemsProvisionForExpectedAllowedClaims contextRef="c131" decimals="-6" id="ixv-7954" unitRef="usd">30000000</us-gaap:DebtorReorganizationItemsProvisionForExpectedAllowedClaims>
    <us-gaap:DebtorReorganizationItemsProvisionForExpectedAllowedClaims contextRef="c132" decimals="-6" id="ixv-7955" unitRef="usd">30000000</us-gaap:DebtorReorganizationItemsProvisionForExpectedAllowedClaims>
    <us-gaap:LossContingencyAccrualProvision contextRef="c2" decimals="-6" id="ixv-7956" unitRef="usd">215000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:DebtorReorganizationItemsProvisionForExpectedAllowedClaims contextRef="c132" decimals="-6" id="ixv-7957" unitRef="usd">30000000</us-gaap:DebtorReorganizationItemsProvisionForExpectedAllowedClaims>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c0" id="ixv-4619">&lt;div&gt;
   &lt;span style="font-weight: bold;"&gt;Note 13.&#160;&#160;Segment and Related Information&lt;/span&gt;
  &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;The Company determines its operating segments based on the discrete financial information that is regularly evaluated by its chief operating decision maker, our Chief Executive Officer, in deciding how to allocate resources and in assessing performance.&#160;The Company&#x2019;s operating segments are strategic business units that offer different products and serve different markets.&#160;They are managed separately and require different technology and marketing strategies.&#160;&#160;&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt; &lt;span&gt;The Company has two reportable segments: Consumer &amp;amp; Specialties and Engineered Solutions. See Note 1 to the Condensed Consolidated Financial Statements. &lt;/span&gt; &lt;/div&gt;
  &lt;div style="text-align: justify;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="text-indent: 36pt; text-align: justify;"&gt;
   &lt;span&gt;The Company evaluates performance based on the operating income of the respective business units.&#160;The costs deducted to arrive at operating profit do not include several items, such as net interest or income tax expense.&#160;Depreciation expense related to corporate assets is allocated to the business segments and is included in their income from operations.&#160;However, such corporate depreciable assets are not included in the segment assets.&#160;Intersegment sales and transfers are not significant.&lt;/span&gt;
  &lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span&gt;Segment revenues, expenses, operating income, and a reconciliation of the operating segment totals to the applicable line items on the Condensed Consolidated Financial Statements is as follows for the three-month periods ended April 5, 2026 and March 30, 2025 is as follows:&lt;/span&gt; &lt;/div&gt;&lt;div&gt;&#160;&lt;/div&gt;

  &lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="23" style="text-align: center; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; font-weight: bold;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="11" style="text-align: center; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; font-weight: bold;"&gt;Apr. 5, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="11" style="text-align: center; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; font-weight: bold;"&gt;Mar. 30, 2025&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; white-space: nowrap;"&gt;Consumer &amp;amp;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center;"&gt;Engineered&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; white-space: nowrap;"&gt;Consumer &amp;amp;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center;"&gt;Engineered&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Specialties&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Solutions&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Total&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Specialties&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Solutions&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Total&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Net sales&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;296.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;250.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;546.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;268.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;223.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;491.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Cost of goods sold&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;240.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;175.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;415.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;215.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;156.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;372.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;     Segment production margin&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;55.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;75.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;131.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;52.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;67.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;119.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align : bottom; "&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;Marketing and administrative expenses&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;19.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: bottom;"&gt;33.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;53.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;19.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;30.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;49.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Research and development expenses&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;3.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;2.7&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;6.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;3.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;2.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;5.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Restructuring and other items&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;0.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;3.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;     Segment income from operations&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;32.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;39.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;71.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;27.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;33.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;61.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&#160;&lt;/div&gt;






  &lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Apr. 5,&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Mar. 30,&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Segment income from operations&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;71.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;61.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Interest expense, net&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(13.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(14.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Other non-operating income (deductions), net&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(2.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Unallocated expenses:&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;     Provision for litigation accrual and credit losses&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;215.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding-left: 10px;"&gt;     Restructuring and other items&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;     Litigation expenses&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;8.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding-left: 10px;"&gt;     Unallocated corporate expenses&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-left: none; border-right: none; border-bottom: 1px solid black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;"&gt;4.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;"&gt;1.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E13"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 20px;"&gt;Income (loss) before tax and equity in earnings&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-left: none; border-right: none; border-bottom: 3px double black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;"&gt;45.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;"&gt;(176.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E14"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&#160;&lt;/div&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span style="font-size: 9.5pt;"&gt;&lt;span style="font-size: 10pt"&gt;Segment information is as follows for the three-month periods ended April 5, 2026 and March 30, 2025:&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;&lt;div style="font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; font-weight: bold;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;Depreciation, Depletion, and Amortization&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Consumer &amp;amp; Specialties&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;11.7&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;10.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Engineered Solutions&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;13.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;12.7&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;     Total&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;24.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;23.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold;"&gt;Capital Expenditures&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Consumer &amp;amp; Specialties&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;13.7&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;11.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Engineered Solutions&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;8.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;5.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E13"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Corporate&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C14"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;0.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E14"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;1.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E14"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;     Total&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C15"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;23.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C15"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E15"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;18.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E15"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-indent: 36pt;"&gt;&lt;span&gt;The Company&#x2019;s segment assets as of April 5, 2026 and December 31, 2025 are as follows:&lt;/span&gt; &lt;/div&gt;&lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Apr. 5,&lt;/td&gt;&lt;td title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center;"&gt;Dec. 31,&lt;/td&gt;&lt;td title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;"&gt;2026&lt;/td&gt;&lt;td style="border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;"&gt;2025&lt;/td&gt;&lt;td style="border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;Segment Assets&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Consumer &amp;amp; Specialties&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,330.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,333.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Engineered Solutions&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2,058.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2,043.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Corporate&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;75.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;91.7&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;     Total&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;3,465.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;3,469.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&#160;&lt;/div&gt;&lt;div style="text-indent: 36pt;"&gt; &lt;span&gt;The Company&#x2019;s sales by product category are as follows:&lt;/span&gt; &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;


  &lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="font-weight: bold; text-align: center; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center;"&gt;Apr. 5,&lt;/td&gt;&lt;td title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center;"&gt;Mar. 30,&lt;/td&gt;&lt;td title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Household &amp;amp; Personal Care&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;142.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;123.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Specialty Additives&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;154.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;145.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;High-Temperature Technologies&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;183.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;169.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Environmental &amp;amp; Infrastructure&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;67.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;54.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;     Total&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;546.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;491.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c0"
      decimals="INF"
      id="ixv-7958"
      unitRef="Segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c0" id="ixv-4648">&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span&gt;Segment revenues, expenses, operating income, and a reconciliation of the operating segment totals to the applicable line items on the Condensed Consolidated Financial Statements is as follows for the three-month periods ended April 5, 2026 and March 30, 2025 is as follows:&lt;/span&gt; &lt;/div&gt;&lt;div&gt;&#160;&lt;/div&gt;

  &lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="23" style="text-align: center; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; font-weight: bold;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="11" style="text-align: center; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; font-weight: bold;"&gt;Apr. 5, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="11" style="text-align: center; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; font-weight: bold;"&gt;Mar. 30, 2025&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; white-space: nowrap;"&gt;Consumer &amp;amp;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center;"&gt;Engineered&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; white-space: nowrap;"&gt;Consumer &amp;amp;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center;"&gt;Engineered&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Specialties&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Solutions&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Total&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Specialties&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Solutions&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;Total&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Net sales&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;296.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;250.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;546.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;268.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;223.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;491.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Cost of goods sold&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;240.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;175.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;415.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;215.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;156.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;372.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;     Segment production margin&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;55.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;75.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;131.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;52.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;67.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;119.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align : bottom; "&gt;&lt;td style="text-indent: -10px; padding-left: 10px;"&gt;Marketing and administrative expenses&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;19.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: bottom;"&gt;33.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;53.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;19.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;30.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;49.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Research and development expenses&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;3.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;2.7&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;6.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;3.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;2.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;5.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: initial; border-style: none; border-color: initial;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Restructuring and other items&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;0.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;3.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;     Segment income from operations&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;32.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;39.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;71.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - G11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;27.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - I11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;33.6&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - K11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;61.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG1 - Minerals Technologies XBRL 10Q Q3 2025 - M11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span style="font-size: 9.5pt;"&gt;&lt;span style="font-size: 10pt"&gt;Segment information is as follows for the three-month periods ended April 5, 2026 and March 30, 2025:&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;&lt;div style="font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none; font-weight: bold;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Apr. 5,&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%;"&gt;Mar. 30,&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black; width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;Depreciation, Depletion, and Amortization&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Consumer &amp;amp; Specialties&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;11.7&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;10.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Engineered Solutions&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;13.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;12.7&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;     Total&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;24.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;23.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold;"&gt;Capital Expenditures&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Consumer &amp;amp; Specialties&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;13.7&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;11.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Engineered Solutions&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;8.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;5.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E13"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Corporate&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C14"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;0.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E14"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;1.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E14"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;     Total&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C15"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;23.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - C15"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E15"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;18.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG3 - Minerals Technologies XBRL 10Q Q3 2025 - E15"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c60" decimals="-5" id="ixv-7959" unitRef="usd">296600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c62" decimals="-5" id="ixv-7960" unitRef="usd">250300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c138" decimals="-5" id="ixv-7961" unitRef="usd">546900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c61" decimals="-5" id="ixv-7962" unitRef="usd">268300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c63" decimals="-5" id="ixv-7963" unitRef="usd">223500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c139" decimals="-5" id="ixv-7964" unitRef="usd">491800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c60" decimals="-5" id="ixv-7965" unitRef="usd">240800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c62" decimals="-5" id="ixv-7966" unitRef="usd">175000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c138" decimals="-5" id="ixv-7967" unitRef="usd">415800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c61" decimals="-5" id="ixv-7968" unitRef="usd">215800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c63" decimals="-5" id="ixv-7969" unitRef="usd">156400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c139" decimals="-5" id="ixv-7970" unitRef="usd">372200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c60" decimals="-5" id="ixv-7971" unitRef="usd">55800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c62" decimals="-5" id="ixv-7972" unitRef="usd">75300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c138" decimals="-5" id="ixv-7973" unitRef="usd">131100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c61" decimals="-5" id="ixv-7974" unitRef="usd">52500000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c63" decimals="-5" id="ixv-7975" unitRef="usd">67100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c139" decimals="-5" id="ixv-7976" unitRef="usd">119600000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c60" decimals="-5" id="ixv-7977" unitRef="usd">19900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c62" decimals="-5" id="ixv-7978" unitRef="usd">33300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c138" decimals="-5" id="ixv-7979" unitRef="usd">53200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c61" decimals="-5" id="ixv-7980" unitRef="usd">19100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c63" decimals="-5" id="ixv-7981" unitRef="usd">30300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c139" decimals="-5" id="ixv-7982" unitRef="usd">49400000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c60" decimals="-5" id="ixv-7983" unitRef="usd">3400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c62" decimals="-5" id="ixv-7984" unitRef="usd">2700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c138" decimals="-5" id="ixv-7985" unitRef="usd">6100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c61" decimals="-5" id="ixv-7986" unitRef="usd">3400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c63" decimals="-5" id="ixv-7987" unitRef="usd">2400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c139" decimals="-5" id="ixv-7988" unitRef="usd">5800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c60" decimals="-6" id="ixv-7989" unitRef="usd">0</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c62" decimals="-6" id="ixv-7990" unitRef="usd">0</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c138" decimals="-6" id="ixv-7991" unitRef="usd">0</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c61" decimals="-5" id="ixv-7992" unitRef="usd">2500000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c63" decimals="-5" id="ixv-7993" unitRef="usd">800000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c139" decimals="-5" id="ixv-7994" unitRef="usd">3300000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:OperatingIncomeLoss contextRef="c60" decimals="-5" id="ixv-7995" unitRef="usd">32500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c62" decimals="-5" id="ixv-7996" unitRef="usd">39300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c138" decimals="-5" id="ixv-7997" unitRef="usd">71800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c61" decimals="-5" id="ixv-7998" unitRef="usd">27500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c63" decimals="-5" id="ixv-7999" unitRef="usd">33600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c139" decimals="-5" id="ixv-8000" unitRef="usd">61100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="c0" id="ixv-4912">&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Apr. 5,&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Mar. 30,&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Segment income from operations&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;71.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;61.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Interest expense, net&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(13.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(14.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Other non-operating income (deductions), net&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(2.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Unallocated expenses:&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;     Provision for litigation accrual and credit losses&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;215.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding-left: 10px;"&gt;     Restructuring and other items&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;     Litigation expenses&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;8.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding-left: 10px;"&gt;     Unallocated corporate expenses&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-left: none; border-right: none; border-bottom: 1px solid black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;"&gt;4.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;"&gt;1.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 1px solid black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E13"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 20px;"&gt;Income (loss) before tax and equity in earnings&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-top: none; border-left: none; border-right: none; border-bottom: 3px double black;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;"&gt;45.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - C14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;"&gt;(176.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-left: none; border-right: none; border-bottom: 3px double black; border-top: none;" title="SEG2 - Minerals Technologies XBRL 10Q Q3 2025 - E14"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss contextRef="c140" decimals="-5" id="ixv-8001" unitRef="usd">71800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c141" decimals="-5" id="ixv-8002" unitRef="usd">61100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c140" decimals="-5" id="ixv-8003" unitRef="usd">-13300000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c141" decimals="-5" id="ixv-8004" unitRef="usd">-14200000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c140" decimals="-5" id="ixv-8005" unitRef="usd">500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c141" decimals="-5" id="ixv-8006" unitRef="usd">-2000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:LossContingencyAccrualProvision contextRef="c140" decimals="-6" id="ixv-8007" unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision contextRef="c141" decimals="-5" id="ixv-8008" unitRef="usd">215000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c140" decimals="-6" id="ixv-8009" unitRef="usd">0</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions contextRef="c141" decimals="-5" id="ixv-8010" unitRef="usd">2200000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:LitigationSettlementExpense contextRef="c140" decimals="-5" id="ixv-8011" unitRef="usd">8800000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c141" decimals="-5" id="ixv-8012" unitRef="usd">2800000</us-gaap:LitigationSettlementExpense>
    <mtx:UnallocatedCorporateExpenses contextRef="c140" decimals="-5" id="ixv-8013" unitRef="usd">4300000</mtx:UnallocatedCorporateExpenses>
    <mtx:UnallocatedCorporateExpenses contextRef="c141" decimals="-5" id="ixv-8014" unitRef="usd">1200000</mtx:UnallocatedCorporateExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c0" decimals="-5" id="ixv-8015" unitRef="usd">45900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c2" decimals="-5" id="ixv-8016" unitRef="usd">-176300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:CostDepreciationAmortizationAndDepletion contextRef="c60" decimals="-5" id="ixv-8017" unitRef="usd">11700000</us-gaap:CostDepreciationAmortizationAndDepletion>
    <us-gaap:CostDepreciationAmortizationAndDepletion contextRef="c61" decimals="-5" id="ixv-8018" unitRef="usd">10800000</us-gaap:CostDepreciationAmortizationAndDepletion>
    <us-gaap:CostDepreciationAmortizationAndDepletion contextRef="c62" decimals="-5" id="ixv-8019" unitRef="usd">13200000</us-gaap:CostDepreciationAmortizationAndDepletion>
    <us-gaap:CostDepreciationAmortizationAndDepletion contextRef="c63" decimals="-5" id="ixv-8020" unitRef="usd">12700000</us-gaap:CostDepreciationAmortizationAndDepletion>
    <us-gaap:CostDepreciationAmortizationAndDepletion contextRef="c0" decimals="-5" id="ixv-8021" unitRef="usd">24900000</us-gaap:CostDepreciationAmortizationAndDepletion>
    <us-gaap:CostDepreciationAmortizationAndDepletion contextRef="c2" decimals="-5" id="ixv-8022" unitRef="usd">23500000</us-gaap:CostDepreciationAmortizationAndDepletion>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c60" decimals="-5" id="ixv-8023" unitRef="usd">13700000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c61" decimals="-5" id="ixv-8024" unitRef="usd">11500000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c62" decimals="-5" id="ixv-8025" unitRef="usd">8900000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c63" decimals="-5" id="ixv-8026" unitRef="usd">5800000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c64" decimals="-5" id="ixv-8027" unitRef="usd">500000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c65" decimals="-5" id="ixv-8028" unitRef="usd">1000000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c0" decimals="-5" id="ixv-8029" unitRef="usd">23100000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c2" decimals="-5" id="ixv-8030" unitRef="usd">18300000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock contextRef="c0" id="ixv-5169">&lt;div style="text-indent: 36pt;"&gt;&lt;span&gt;The Company&#x2019;s segment assets as of April 5, 2026 and December 31, 2025 are as follows:&lt;/span&gt; &lt;/div&gt;&lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" class="outdatedWorksheet" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold;"&gt;Apr. 5,&lt;/td&gt;&lt;td title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C3"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center;"&gt;Dec. 31,&lt;/td&gt;&lt;td title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E3"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;"&gt;2026&lt;/td&gt;&lt;td style="border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;"&gt;2025&lt;/td&gt;&lt;td style="border-top: none; border-right: none; border-bottom: 1px solid black; border-left: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;Segment Assets&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: initial; border-style: none; border-color: initial;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Consumer &amp;amp; Specialties&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,330.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,333.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Engineered Solutions&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2,058.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2,043.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Corporate&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;75.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;91.7&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;     Total&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;3,465.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;"&gt;3,469.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 3px double black; border-top: none; border-left: none; border-right: none;" title="SEG4 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets contextRef="c142" decimals="-5" id="ixv-8031" unitRef="usd">1330900000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c143" decimals="-5" id="ixv-8032" unitRef="usd">1333400000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c144" decimals="-5" id="ixv-8033" unitRef="usd">2058500000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c145" decimals="-5" id="ixv-8034" unitRef="usd">2043900000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c146" decimals="-5" id="ixv-8035" unitRef="usd">75900000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c147" decimals="-5" id="ixv-8036" unitRef="usd">91700000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c3" decimals="-5" id="ixv-8037" unitRef="usd">3465300000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c4" decimals="-5" id="ixv-8038" unitRef="usd">3469000000</us-gaap:Assets>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock contextRef="c0" id="ixv-5247">&lt;div style="text-indent: 36pt;"&gt; &lt;span&gt;The Company&#x2019;s sales by product category are as follows:&lt;/span&gt; &lt;/div&gt;
  &lt;div&gt;&#160;
  &lt;/div&gt;


  &lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="font-weight: bold; text-align: center; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;Three Months Ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center;"&gt;Apr. 5,&lt;/td&gt;&lt;td title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C4"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center;"&gt;Mar. 30,&lt;/td&gt;&lt;td title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E4"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="font-weight: bold;"&gt;(in millions of dollars)&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2026&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C5"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;"&gt;2025&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor black;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E5"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Household &amp;amp; Personal Care&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;142.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;123.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Specialty Additives&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;154.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;145.2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;High-Temperature Technologies&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;183.3&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;169.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Environmental &amp;amp; Infrastructure&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;67.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;"&gt;54.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 1px solid black; border-top: none; border-left: none; border-right: none;" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="font-weight: bold; padding-left: 10px;"&gt;     Total&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;546.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;491.8&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="SEG5 - Minerals Technologies XBRL 10Q Q3 2025 - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c148" decimals="-5" id="ixv-8039" unitRef="usd">142400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c149" decimals="-5" id="ixv-8040" unitRef="usd">123100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c150" decimals="-5" id="ixv-8041" unitRef="usd">154200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c151" decimals="-5" id="ixv-8042" unitRef="usd">145200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c152" decimals="-5" id="ixv-8043" unitRef="usd">183300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c153" decimals="-5" id="ixv-8044" unitRef="usd">169400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c154" decimals="-5" id="ixv-8045" unitRef="usd">67000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c155" decimals="-5" id="ixv-8046" unitRef="usd">54100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c0" decimals="-5" id="ixv-8047" unitRef="usd">546900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c2" decimals="-5" id="ixv-8048" unitRef="usd">491800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c0" id="ixv-8049">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c0" id="ixv-8050">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c0" id="ixv-8051">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c0" id="ixv-8052">false</ecd:NonRule10b51ArrTrmntdFlag>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c3"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c4"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentMaturityDate contextRef="c81" id="hidden-fact-2">2031-11-26</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="c109" id="hidden-fact-3">2028-06-30</us-gaap:DebtInstrumentMaturityDate>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-8059">0000891014</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-8060">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-8061">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-8062">--12-31</dei:CurrentFiscalYearEndDate>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-0"
          xlink:label="hidden-fact-0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_31_fact"
          xlink:label="ix_31_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_32_fact"
          xlink:label="ix_32_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Unaudited</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-0"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_56_fact"
          xlink:label="ix_56_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_54_fact"
          xlink:label="ix_54_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_60_fact"
          xlink:label="ix_60_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_51_fact"
          xlink:label="ix_51_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_62_fact"
          xlink:label="ix_62_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_50_fact"
          xlink:label="ix_50_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_49_fact"
          xlink:label="ix_49_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_61_fact"
          xlink:label="ix_61_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_55_fact"
          xlink:label="ix_55_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_41_fact"
          xlink:label="ix_41_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_59_fact"
          xlink:label="ix_59_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_57_fact"
          xlink:label="ix_57_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_34_fact"
          xlink:label="ix_34_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_42_fact"
          xlink:label="ix_42_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_36_fact"
          xlink:label="ix_36_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_33_fact"
          xlink:label="ix_33_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_45_fact"
          xlink:label="ix_45_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_58_fact"
          xlink:label="ix_58_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_64_fact"
          xlink:label="ix_64_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-1"
          xlink:label="hidden-fact-1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_44_fact"
          xlink:label="ix_44_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_43_fact"
          xlink:label="ix_43_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_65_fact"
          xlink:label="ix_65_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_53_fact"
          xlink:label="ix_53_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_35_fact"
          xlink:label="ix_35_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_38_fact"
          xlink:label="ix_38_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_39_fact"
          xlink:label="ix_39_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_40_fact"
          xlink:label="ix_40_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_52_fact"
          xlink:label="ix_52_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_47_fact"
          xlink:label="ix_47_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_37_fact"
          xlink:label="ix_37_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_48_fact"
          xlink:label="ix_48_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_63_fact"
          xlink:label="ix_63_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_46_fact"
          xlink:label="ix_46_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Condensed from audited financial statements</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_56_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_54_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_60_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_51_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_62_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_50_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_49_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_61_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_55_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_41_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_59_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_57_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_34_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_42_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_36_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_45_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_58_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_64_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-1"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_43_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_65_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_53_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_35_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_38_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_39_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_40_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_52_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_47_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_37_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_63_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
